Environmental Toxicants Induced Male Reproductive Disorders: Identification and Mechanism of Action by Kuladip Jana & Parimal C. Sen
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
20 
Environmental Toxicants Induced 
Male Reproductive Disorders: 
Identification and Mechanism of Action 
Kuladip Jana and Parimal C. Sen 
Division of Molecular Medicine, 
 Bose Institute, Kolkata, 
India 
“Several observations on poor trends in Male Reproductive Health have been reported during the last 
Decades. These difficult trends include the increasing prevalence of Testicular Cancer, Low and 
possibly declining Semen Quality, high and possibly rising frequencies of Cryptorchidism 
(Undescended Testis) and malformation of the Penis (Hypospadias) as well as a increasing demand 
for Assisted Reproduction”. 
1. Introduction 
The phrase ‘endocrine disruption’ has seemingly become inextricably linked with terms like 
‘environmental oestrogens’ and ‘falling sperm counts’. While these connections aid 
understanding about these issues, they represent a simplified view of the field of endocrine 
disruption. There is currently no strong data to suggest that environmental endocrine 
disrupters (EDCs) are responsible for the observed disintegration in human male 
reproductive health, but there are secular trends to suggest that it is declining. There is, 
however, very good evidence that lifestyle factors (e.g. smoking, alcohol consumption 
and/or use of cosmetics) can have an impact on fertility (Sharpe & Franks 2002; Sharpe & 
Irvine, 2004). Similarly, the notion that all EDCs act by mimicking oestrogen (environmental 
oestrogens) is too simplistic. The current literature illustrates that EDCs can act as 
oestrogens, anti-oestrogens, anti-androgens, steroidogenic enzyme inhibitors and can also 
act via interaction with the thyroid hormones and their receptors, or within the brain and 
the hypothalamo–pituitary axis, as well as the immune system (Fisher, 2004; Jana et al., 2006; 
2010a). Reports of declining sperm counts over the past 50 years and other disturbing trends 
alerted scientists to the possibility that exposure to chemicals in the environment may 
damage male reproductive health (Carlsen et al., 1992). Testicular cancer, the most common 
malignancy in men 15-44 years of age, has increased markedly in incidence in this century in 
virtually all countries studied. The incidence of hypospadias, a developmental malformation 
of the male urethra, appears to be increasing worldwide. Cryptorchidism (undescended 
testicle), another developmental defect, may have increased in some human populations 
and appears to be increasing in wildlife (Toppari et al., 1996; Fisher, 2004, Sharpe, 2010). The 
causes of these trends have not been identified and relevant toxicological data about male 
reproductive effects of environmental toxicants are limited. Recent research efforts have 
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focused on the possibility that exposures to hormonally active compounds, particularly 
during childhood and in utero, are to blame, at least in part, for changes in semen quality, 
increasing rates of testicular cancer, and malformations of the male urogenital tract (Sharpe, 
2010). The ability to investigate environmental determinants of these indicators of male 
reproductive health is currently limited by available methodologies and data. 
1.1 The male reproductive system: Environmental influence 
Global changes in semen quality are suggested to be produced by the enhanced exposure to 
environmental chemicals contained in pesticides, food sources, cosmetics, plastics, 
electronics, and other synthetic materials (Carlsen et al., 1992). The biological basis for this 
hypothesis is the action of certain chemical compounds, both naturally occurring and 
anthropogenic (man-made), on endogenous hormone receptors and hormone-dependent 
pathways. These chemicals are termed hormonally active agents, environmental estrogens, 
hormone mimics, and endocrine disrupters/disruptors (US. EPA, 1998a; 1998b; National 
Research Council [NRC], 1989). A wide range of mechanisms of action are described for 
endocrine disrupters, including agonists of the estrogen receptor (ER) genistein, 
diethylstilbestrol (DES; Roy et al., 1997), and bisphenol A (BPA; Kuiper et al., 1998); 
androgen receptor (AR) antagonists such as vinclozolin ( Wong et al., 1995), linuron, 
procymidone (Gray et al., 1999), phthalates (Foster et al., 2001), and p,p′-dichlorodiphenyl 
dichloroethylene (p,p′-DDE; Kelce et al., 1995) and aryl hydrocarbon receptor (AhR) 
agonists, which include dioxins (Toyoshiba et al., 2004), polychlorinated biphenyls (PCB), 
polycyclic aromatic hydrocarbons (PAH), and polychlorinated dibenzofurans (PCDF; 
Peterson et al., 1993). Exposure to endocrine-disrupting chemicals may occur through 
environmental routes (air, soil, water, food) or via occupational exposures (Figure 1) 
(Sharpe & Irvine, 2004).  
1.2 The testis: Male reproductive organ 
The testis is both an endocrine gland and a reproductive organ, responsible for the 
production of hormones and male gametes and an important target for endocrine 
disruption. The testis consists of two types of tissues: seminiferous tubules, supported by 
Sertoli cells, and the interstitial compartment, comprised of Leydig cells (Fisher, 2004; 
Akingbemi, 2005). Testicular functions (spermatogenesis steroidogenesis) are regulated by 
the hypothalamic-pituitary-testicular (HPT) axis which involves the pituitary gonadotropins 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH; Jana et al., 2006). 
Testicular functions are proposed to be regulated by a number of hormones and growth 
factors in addition to FSH, LH, and androgens, including insulin-like growth factor, 
oxytocin, and transforming growth factor-ǂ and estrogens (Pryor et al., 2000). 
1.2.1 Spermatogenesis 
Spermatogenesis is the formation of the male gamete or spermatozoa. Spermatogenesis is 
dependent on the integrity of the architecture of the seminiferous tubules and Sertoli cells 
and endocrine regulation and is regulated by testosterone and FSH. In response to LH, 
Leydig cells produce androgens, including testosterone, which along with FSH bind to their 
respective Sertoli cell receptors to regulate spermatogenesis. Spermatogenesis requires 
unique associations between Sertoli cells and developing male germ cells such that the 
seminiferous tubules are lined by Sertoli cells and joined by tight junctions forming the  
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Fig. 1. Routes of human exposure to some common environmental chemicals. DDE= 1, 1-
dichloro-2, 2-bis (p- chlorophenyl) ethylene; DDT= dichlorodiphenyltrichloroethane; 
PAHs= polycyclic aromatic hydrocarbons; PCBs= polychlorinated biphenyls. (Modified 
from Sharpe & Irvine, BMJ, 2004). 
blood–testis barrier (BTB; Walker & Cheng, 2005). There are three major phases of 
spermatogenesis: (1) spermatogonial phase, (2) spermatocyte phase, and (3) spermatid 
phase (Figure 2). In the first phase the diploid spermatogonia undergo mitosis and create 
stem cells and diploid primary spermatocytes. During the second phase the primary 
spermatocytes undergo two rounds of meiosis, producing haploid spermatids. Finally, the 
spermatids begin a differentiation phase, sometimes referred to as spermiogenesis, during 
which the immature gametes develop into mature spermatozoa (O’Donnell et al., 2001). 
Spermatids continue their differentiation (spermiogenesis) while physically associated with 
the Sertoli cells. Spermiogenesis includes polarization of the spermatid, formation of the 
acrosome cap and flagellum, condensation, elongation of the nucleus, and cytoplasmic re-
modelling to produce the characteristic appearance of the mature spermatozoa. 
Spermatozoa are morphologically mature but immotile and are then released into the lumen 
of the seminiferous tubules (spermiation). At this stage these immotile testicular 
spermatozoa are not yet capable of fertilization (O’Donnell et al., 2001). The BTB between 
Sertoli cells comprises a co-existing tight junction (TJ), desmosome, gap junction and a testis-
specific adherens junction (AJ) called the basal ectoplasmic specialization (ES). The basal ES 
is typified by the presence of actin filament bundles ‘sandwiched’ between the plasma 
membrane and the cisternae of endoplasmic reticulum in two neighbouring Sertoli cells. 
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However, recent studies show that the unique structural aspects of the BTB, such as the 
presence of focal adhesion protein FAK, also render the testis highly susceptible to damage 
from environmental toxicants. Third, during spermiogenesis when round spermatids 
differentiate into elongated spermatids, genetic material in the spermatid head condense to 
form the tightly packed nucleus with the formation of an acrosome above the head region 
and elongation of the spermatid tail. During this time, spermatids migrate towards the 
adluminal compartment of the seminiferous tubule until elongated spermatids are released 
into the tubule lumen via the disassembly of another ES, the apical ES, at spermiation. The 
apical ES anchors developing spermatids in the seminiferous epithelium until they are fully 
developed. Thus, disruption of the apical ES (e.g. by environmental toxicants) causes the 
premature release of spermatids that are structurally defective (e.g. lack of acrosome and/or 
tail) and which are incapable of fertilizing the ovum (Wong & Cheng, 2011). 
 
   
Fig. 2. The process of normal mammalian spermatogenesis with three major phases: (1) 
spermatogonial phase, (2) spermatocyte phase, and (3) spermatid phase. 
1.2.2 Sperm maturation 
The immotile spermatozoa are transported from the lumen of the seminiferous tubules by 
peristaltic contractions of adjacent myoid cells. The spermatozoa are suspended in a fluid 
secreted by Sertoli cells and migrate through a series of ductules within the testis (rete 
testis), passing through the efferent ductules and eventually entering the epididymis. The 
efferent ductules concentrate the spermatozoa by reabsorbing fluid (O’Donnell et al., 2001). 
There is evidence from transgenic mice that this fluid resorption is regulated by estrogen 
(Hess et al., 1997). The segments of the epididymis, caput, corpus, and cauda secrete 
proteins, and endocytose secreted proteins from the epididymal lumen to contribute to the 
maturation of the spermatozoa (O’Donnell et al., 2001). It is within the epididymis that the 
spermatozoa gain motility machinery. However, these spermatozoa remain immotile as 
they are pushed through the rest of the reproductive tissues via peristaltic contractions. It is 
during this final passage that seminal fluid is produced by the seminal vesicles, which 
contributes about 70% to the semen, and the prostate gland, which contributes another 10–
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30%. Seminal fluid is comprised of proteins, enzymes, fructose, mucus, vitamin-C, flavins, 
phosphorylcholine, and prostaglandins (Purvis et al., 1986). Decreases in seminal fluid 
volume may therefore indicate diminished seminal vesicle or prostate functions. 
1.3 The role of androgens in male reproductive tract development 
Male reproductive tract development is a dynamic process requiring the interaction of many 
factors and hormones. One of the major factors essential for the development of the male 
internal and external male reproductive tract are the androgens, testosterone and 
dihydrotestosterone (DHT) (Phillips & Tanphaichitr, 2008). Androgens are produced by the 
testes during fetal and neonatal development and are essential for the maintenance of the 
Wolffian duct that differentiates into the epididymis, vas deferens and the seminal vesicles. 
The masculinization of these reproductive structures is mediated by testosterone. The 
masculinization of the external genitalia and prostate is largely mediated by DHT which is a 
more potent metabolite of testosterone and is produced by the action of the enzyme 5ǂ-
reductase. The central role of androgens in driving these developmental processes illustrates 
why chemicals that can interfere with the synthesis or action of androgens can have 
deleterious consequences for the developing male genital tract. Administration of the anti-
androgen, flutamide (an androgen receptor antagonist), during male reproductive tract 
development resulted in abnormalities in the formation of the external genitalia - 
hypospadias and cryptorchidism; internally, agenesis of the epididymis, vas deferens and 
prostate (Mylchreest et al., 2000). Within the testis, degeneration of the seminiferous 
epithelium and Leydig cell  hyperplasia were common (although this may be a consequence 
of the cryptorchidism rather than an anti-androgenic effect). The male pups also displayed 
retained thoracic nipples and a reduced anogenital distance (feminised) which are both 
indicative of reduced androgen action in fetal life (Mylchreest et al., 2000). In summary, both 
testosterone- and DHT-mediated male reproductive tract development is impaired by 
flutamide when administered over the period of reproductive tract differentiation.  
1.4 Problems with male reproductive health 
1.4.1 Semen quality 
Reports suggesting that sperm counts have declined in certain areas of industrialized 
countries throughout the world have contributed to concern about a possible worldwide 
decline in human semen quality (Swan et al., 1997). A meta-analysis by Carlsen et al.,(1992) 
reported a worldwide decline in sperm counts over the preceding 50 years, concluding that 
mean sperm concentrations had decreased by almost 50% from 1940 to 1990. Numerous 
researchers have attempted to determine whether this apparent decline is real or due to 
unrecognized biases in data collection and analysis. Confounding Variables may account for 
the observed findings. Potential confounders include increasing donor age, duration of 
abstinence, frequency of ejaculation, and even the season of sample collection, all of which 
influence sperm variables. Other suggested confounders include smoking, chemicals and 
radiation exposures, stress, ethnicity, and a variety of physical conditions including 
varicocele, infection, and genital abnormalities such as hypospadias and cryptorchidism. 
Theories explaining the apparent geographic disparities in sperm counts are currently only 
speculative, and include environmental, socioeconomic, racial, and methodologic 
differences (Swan et al., 1997). Fisch et al., (1996) reported yearly fluctuations in mean sperm 
counts and birth rates (Fisch et al., 1997), suggesting that this may be a more important 
variable than previously considered. 
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1.4.2 Testicular cancer 
Testicular cancer is often quoted as the commonest cancer of young men. The secular trends 
across Europe and the United States show that it is increasing in incidence in Caucasian men 
(SEER 2003). There is widespread geographical variation and the incidence of testicular 
cancer can vary up to 10-fold between countries. In Denmark in 1980, the age standardised 
incidence rate per 100 000 population was 7.8% whereas in Lithuania it was 0.9%, although 
in all countries where registry data has been analysed there was an annual increase of 2.3–
3.4% (Adami et al., 1994). The increase in testicular cancer has been linked to a birth cohort 
effect, suggesting that factors affecting in utero development may be important (Bergstrom 
et al., 1996). Testicular germ cell cancer arises from cells which have similar characteristics to 
fetal germ-cells; these pre-malignant cells are termed carcinoma-in situ (CIS) cells (Rajpert-
De Meyts et al., 2003). How these cells persist during development and what causes them to 
proliferate after puberty is not well understood, although it is thought that the factors that 
promote normal germ cell division may also be important in promoting CIS proliferation. 
Abnormal intrauterine hormone levels i.e. decreased androgen and/or increased oestrogen 
levels are believed to be important in the occurrence of testicular cancer (Sharpe & 
Skakkebaek 1993). Similarly, decreased androgen and/or increased oestrogen levels have 
also been implicated in the occurrence of cryptorchidism, hypospadias and low sperm 
counts (Sharpe & Skakkebaek 1993). Although genetics almost certainly plays a major role in 
the etiology of the disease, other etiologies, including environmental factors, need to be 
elucidated to explain why, for example, major differences in testicular cancer rates exist 
among the relatively genetically homogenous Scandinavian countries. Increases in testicular 
cancer rates are not recent phenomena. A doubling in incidence was documented in 
Denmark within 25 years after the initiation of cancer registration in 1943 (Ekbom & Akre, 
1998). Mortality data from Great Britain show an increase in mortality due to testicular 
cancer beginning in the 1920s (Davies, 1981). These mortality data raise an important 
distinction: if environmental risk factors play a role in testicular cancer incidence, relevant 
exposures must therefore have existed since the turn of the century. This would make it less 
likely that organochlorines such as DDT and other endocrine-disrupting chemicals are 
possible etiologic agents. Research is ongoing to explore new genetic markers for early 
detection of carcinoma in situ cells in semen, as well as to define the role of hormonal assays 
(e.g., inhibin-B) as screening tools for testicular cancer and carcinoma in situ. 
1.4.3 Congenital abnormalities (Cryptorchidism and hypospadias) 
Cryptorchidism and hypospadias are abnormalities normally detected at birth (congenital 
abnormalities). Cryptorchidism occurs when the testis does not descend into the scrotal sac; 
this is generally unilateral but can be bilateral. Hypospadias is a developmental abnormality 
of the penis in which the urethral opening is not located at the tip of the glans penis but can 
occur anywhere along the shaft. Determining whether there is a real increase in hypospadias 
and/or cryptorchidism is confounded by changes in diagnostic criteria and recording 
practices which make the registry data unreliable (Toppari et al., 1996). Despite this, 
cryptorchidism is the most common congenital abnormality of the newborn (2–4% 
incidence) and trends for hypospadias suggest a progressive increase; based on registry 
data, hypospadias is the second most common (0.3–0.7% at birth) congenital malformation 
(Sharpe, 2003). Prospective studies are underway, which employ standardised diagnostic 
criteria, to collect robust data about the current incidence of cryptorchidism and 
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hypospadias. This will allow the monitoring of future trends and allow international 
comparisons on the incidences of these disorders. However, two male genital birth defects, 
hypospadias and cryptorchidism, both apparently representing mild degrees of 
feminization, have become important in the ongoing debate regarding the significance of 
endocrine disruptors or other environmental influences on male development (Sharpe & 
Skakkebaek, 1993). Several researchers have reported increases in each of these defects in 
the past three decades. To evaluate the hypothesis of common etiologies, pre- and peri-natal 
determinants of hypospadias, cryptorchidism, testicular cancer, and infertility are under 
investigation. Abnormal sex hormone exposure during critical periods of development has 
been postulated as a likely shared pathologic mechanism (Toppari et al., 1996).  
1.4.4 There is a link between these male reproductive health issues 
The strongest evidence suggesting a link between these male reproductive tract disorders, 
aside from the (largely imperfect) data which suggests they are all increasing in incidence, is 
the fact that epidemiologically the occurrence of one disorder is a risk factor for the 
occurrence of another (Skakkebaek et al., 2001, Sharpe, 2003). This has led to the proposal 
that low sperm counts, hypospadias, cryptorchidism and testicular germ cell cancer are 
interrelated disorders comprising a ‘testicular dysgenesis syndrome’ (TDS; Skakkebaek et 
al., 2001, Sharpe, 2003, 2010; Figure 3). The disorders that comprise TDS all have their roots 
in fetal development, suggesting that a possible causal link lies in abnormal hormone 
synthesis or action during reproductive tract development. From the historical literature, it 
is well known that the administration of diethylstilboestrol (DES; a potent synthetic 
oestrogen) to pregnant humans and rodents causes reproductive tract abnormalities in the 
offspring (Stillman, 1982). In male rodents, neonatal administration of DES induces a 
reduction in the number of Sertoli cells (the major somatic cell type which supports 
spermatogenesis) (Sharpe et al., 2003). There is also data suggesting DES administration to 
humans induces an increase in the incidence of cryptorchidism, although it is less certain 
whether hypospadias and testicular cancer show any significant increase (Stillman, 1982). 
DES only induces male reproductive tract abnormalities after administration at very high 
doses, which are probably not relevant to environmental considerations. However, what is 
of more concern is that, when administered at high doses, DES and other potent oestrogens 
are capable of reducing androgen levels and expression of the androgen receptor protein 
relative to control rats (McKinnell et al., 2001, Rivas et al., 2002). This raises the important 
question of whether some of the genital tract abnormalities that arise from in utero 
administration of potent oestrogens are caused by lowered androgen levels and/or action.  
1.5 Anti-androgenic compounds in the environment 
There are a number of commonly used environmental chemicals that have been identified as 
having anti-androgenic properties. These chemicals have been administered to pregnant 
rodents during the period of reproductive tract development. When the male pups were 
examined, they displayed many of the abnormalities associated with flutamide 
administration. Some chemicals (vinclozolin, procymidone, linuron, p,p′DDE (1,1,1-
dichloro-2,2-bis(p-chlorophenyl)ethane) act as androgen receptor antagonists, others 
(phthalate esters) reduce androgen synthesis, but it is likely that other modes of action are 
also involved in the toxicity induced by these compounds (Gray et al.,2001). The following 
sections provide information on a few well-characterised examples of anti-androgenic 
www.intechopen.com
 
Toxicity and Drug Testing 480 
compounds (i.e. vinclozolin, linuron, p,p′ DDE and phthalates etc.) and common 
environmental toxins reported to be involved in male reproductive toxicity. 
 
 
Fig. 3. Testicular dysgenesis syndrome. Both genetic and environmental factors affect 
testicular development and functions. Damage of the testicular cells (Leydig cells and Sertoli 
cells), disrupts androgen production from Leydig cells and secretion of paracrine factors 
from sertoli cells, leading to birth defects (hypospadias, cryptorchidism) and impaired germ 
cell differentiation, apparent later as reduced semen quality or in the worst cases as 
carcinoma in situ (CIS) of the testis and consequent testicular cancer. (Modified from 
Skakkeback et al. Human Reproduction, 2001). 
1.5.1 Polychlorinated Biphenyls (PCB) 
PCB make up a group of synthetic organic chemicals containing about 200 individual 
compounds. Some PCB bind to ERs and consequently PCB may exert their toxic effects 
through estrogenic activity (McKinney & Waller, 1998). Alternatively, some PCB may 
produce reproductive toxicity through the production of free radicals. Rats exposed to 
mixtures of PCB demonstrated decreased superoxide dismutase and catalase activity in the 
testes following exposure (Peltola et al., 1994). PCB congeners have different mechanisms of 
action and therefore different effects on biological systems. Longitudinal studies of children 
with in utero or lactational exposure to PCB and other environmental chemicals are essential 
to assess the long-term effects of endocrine disruption. Prenatal and lactational exposure to 
PCB may exert adverse effects on male reproduction during subsequent adulthood. A well-
studied population exposed to PCB/PCDF-contaminated rice oil (Yu-Cheng exposure; 
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Taiwan 1978–79) was followed to determine effects on male reproductive health. Median 
serum PCB levels measured in Yu-Cheng mothers was 26.8 ng/ml: a relatively high PCB 
exposure that would be expected to affect fetal development. Sexual development and 
semen quality were evaluated in Yu-Cheng sons, aged 16 yr and older. Seminal volume and 
sperm concentration were not different between exposed and control boys. However, 
proportions of sperm with normal morphology and motility were reduced in exposed boys 
(Guo et al., 2000). The effects of PCB exposure on semen quality in men from the general 
population appear to affect differentiation of spermatids (spermiogenesis) and post-
testicular development (sperm maturation), which would manifest as decreased sperm 
morphology and motility, respectively. Further studies of PCB exposure—both individual 
congeners and PCB mixtures—and sperm parameters are required. 
1.5.2 DDT and p,p ′-DDE 
The persistent pesticide, DDT, is broken down in the environment, and one of its 
metabolites is p,p′-DDE, which has been shown to act as an androgen receptor antagonist 
both in vivo and in vitro (Kelce et al.,  1995). Studies in which p,p′-DDE was administered to 
rats during development (gestational day (GD)14–18; 100 mg/kg/day) affected androgen-
dependent aspects of male development such that it reduced anogenital distance, caused 
nipple retention and, depending on the rat strain, induced hypospadias (You et al., 1998). 
Another DDT derivative, methoxychlor and its metabolites, have been shown to interact 
with both oestrogen receptors and the androgen receptor (AR). The methoxychlor 
metabolite, 1,1-Trichloro-2,2-bis (4 hydroxyphenyl) ethane, is an oestrogen receptor (ER)- ǂ 
agonist, an ER-ǃ antagonist and an androgen receptor (AR) antagonist (Gray et al., 2001). 
This illustrates that these chemicals may act by more than one mechanism to induce effects 
on the exposed population. Moreover, several population studies conducted to examine the 
effects of DDT and metabolite exposure on male reproductive health support the hypothesis 
that DDT exposure is related to reduced semen quality. Significantly higher seminal 
concentrations of p,p′-DDE were also reported in infertile patients compared to a fertile 
control group in India. Seminal fluid levels of fructose, Ǆ-glutamyl transpeptidase, and acid 
phosphatase were positively correlated with p,p′-DDE concentrations in infertile men. The 
high concentration of fructose, a marker for seminal vesicle function and an important 
energy source for sperm, may indicate non-utilization of fructose by sperm. DDT exposure 
may be associated with abnormal metabolism in sperm, including decreased fuel utilization, 
in infertile men (Pant et al., 2004). Mexican men living in the areas where DDT was used for 
malaria control, but without occupational exposure to DDT, exhibited serum levels of p,p′-
DDE approximately 350-fold greater than Canadian men exposed to background 
environmental levels. p,p′-DDE concentrations in the Mexican men were correlated with 
increases in SHBG concentration and negatively correlated with testosterone levels. Both 
semen volume and total sperm number were inversely correlated to p,p'-DDE levels. Thus, 
androgen levels and semen quality are adversely affected by high p,p′-DDE body burden 
(Ayotte et al., 2001). The studies examining DDT exposure and semen quality report 
consistent effects on sperm motility and sperm morphology, similar to the PCB studies. The 
increased SHBG concentrations associated with serum p,p′-DDE described by Ayotte et 
al.,(2001) provides a possible mechanism for observed reductions in plasma testosterone and 
sperm number. By inducing SHBG synthesis, p,p′-DDE may exert its antiandrogenic effects 
by reducing the amount of bioavailable testosterone, thereby impairing spermatogenesis. 
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Further, more extensive correlation studies on the serum levels of DDT and metabolites in 
mothers of infertile men are required. These studies would provide insight into the effects of 
in utero exposure to DDT on semen quality of adult males.  
1.5.3 Dioxins 
Tetrachlodibenzo-p-dioxin (TCDD) is a carcinogen, demonstrated to target the endocrine 
system in experimental animals. Humans are exposed to dioxins through pulp and paper 
industry emissions, use of contaminated herbicides (now reduced in industrialized 
countries), and waste incineration emissions. Dioxins are lipophilic, slowly metabolized, 
and thus are not easily eliminated leading to bioaccumulation. Secondary dioxin exposures 
include dietary uptake via contaminated breast milk, meat, fish, and other dairy. Dioxins 
along with polycyclic aromatic hydrocarbons (PAH) and polyhalogenated biphenyls bind to 
the aryl hydrocarbon receptor (AhR). AhR ligands induce cell proliferation, differentiation, 
and apoptosis, although the mechanisms of these stimulations are not fully understood. It is 
known that human sperm possess AhR and may therefore be directly susceptible to dioxin 
(Khorram et al., 2004). A range of endocrine effects are reported in experimental animals 
following dioxin exposure. These include disruption of the HPT axis feedback mechanisms 
leading to alterations in serum levels of testosterone, dihydrotestosterone (DHT), E2, and 
LH, as well as modifications of the metabolism processes/events of estrogens and 
androgens (Birnbaum & Tuomisto, 2000). There are few published studies reporting human 
exposure to dioxins. Agent Orange, which contains TCDD as its contaminant, was used 
during the Vietnam War and exposure was documented in veterans of Operation Ranch 
Hand (the unit responsible for aerial herbicide spraying in Vietnam from 1962 to 1971; 
(Stone, 2007). Detectable TCDD levels in serum and seminal plasma were evident in U.S. 
veterans two to three decades following their Vietnam military service. Reproductive 
parameters including serum testosterone, FSH, LH, and testicular abnormalities were not 
associated with serum TCDD levels in the exposed men. It may be possible that the effects of 
dioxin on reproductive parameters were no longer evident at the time of the study, several 
decades after the use of Agent Orange. As semen quality can only be evaluated by follow-up 
study, the acute effects of exposure to Agent Orange on male reproductive health are 
unknown. Another study of 101 men from the general population in Belgium assessed 
TCDD exposure and semen quality. TCDD exposure was measured as dioxin-like activity in 
serum. Increases in serum dioxin-like activity were associated with decreased seminal 
volume resulting in elevated sperm concentrations. Total testosterone levels were 
significantly reduced in men with high serum dioxin-like activity. However, there was no 
significant association with LH, inhibin B, FSH, total sperm numbers, or sperm morphology 
(Dhooge et al., 2006). There are few epidemiological studies evaluating reproductive 
outcomes and particularly semen quality following TCDD and dioxin exposure. However, it 
is more relevant to consider the effects of dioxin at environmental concentrations on male 
reproductive health. A possible mechanism for infertility may be mediated by dioxin 
interacting with AhR on human sperm with implications for capacitation, acrosome 
reaction, sperm–egg binding, and fertilization. More studies are required to examine the 
effects of dioxin on semen quality.  
1.5.4 Phthalates esters 
Phthalate esters are abundant industrial chemicals used in the production of plastics and are 
present in many personal care products including cosmetics. Phthalates are a family of 
www.intechopen.com
Environmental Toxicants Induced 
Male Reproductive Disorders: Identification and Mechanism of Action 483 
compounds and only a few induce male reproductive tract abnormalities. Gray et al., (2000) 
compared the ability of six phthalate esters (diethylhexyl phthalate, DEHP; benzylbutyl 
phthalate, BBP; diisononyl phthalate, DINP; dimethyl phthalate, DMP; diethyl phthalate, 
DEP; dioctyl terephthalate, DOTP; all administered at 750 mg/kg body weight from GD14 
to postnatal day (PND) 3) to induce malformations of the reproductive tract. This study 
assessed changes in many androgenic endpoints and found that only DEHP, BBP and to a 
lesser degree DINP induced alterations in all aspects of androgen-regulated male 
reproductive endpoints. Exposure to diethyl hexyl and dibutyl phthalates is associated with 
adverse effects on sperm motility (Fredricsson et al., 1993). Animal studies consistently 
demonstrated that phthalate esters are male reproductive toxicants (Park et al., 2002), with 
exposure associated with testicular atrophy, spermatogenetic cell loss, and damage to the 
Sertoli cell population. Phthalate monoesters target Sertoli cell functions in supporting the 
spermatogenesis process. This may be due to the effect of phthalates in reducing the ability 
of Sertoli cells to respond to FSH (Hauser et al., 2005). Initial reports on the effects of 
phthalates on male reproductive tract development focussed on the gross changes such as 
reduced anogenital distance, hypospadias, malformed epididymis and, in later studies, 
nipple retention (Mylchreest et al., 2000). Only a few studies give a more detailed account of 
the histological changes observed in the testis after in utero phthalate exposure and 
demonstrate that the fetal testis is directly affected by phthalates during fetal and neonatal 
testis differentiation (Parks et al., 2000; Fisher et al., 2003). Some of these alterations are 
permanent and affect the function of the testis in adult life and are similar to the histological 
changes which are now being shown in patients with testicur dysgenesis syndrome (TDS; 
Skakkebaek et al., 2003). The production of testosterone is critical for the normal 
masculinization of the male reproductive tract, as already discussed. It has been shown that 
DBP and DEHP are both capable of inhibiting the production of testosterone by the fetal 
testis (Parks et al., 2000; Fisher et al., 2003). Testosterone synthesis by the fetal testis is first 
detectable by GD15, reaches a peak at around GD18/19, and remains high until birth. 
However, phthalate treatment induces a 60–85% reduction in testosterone synthesis during 
this critical developmental window, reducing testosterone levels to a similar level to those 
found in females (Parks et al., 2000). This reduction in testosterone is a factor in the 
occurrence of hypospadias and cryptorchidism observed after phthalate treatment. This is 
not to suggest that phthalate exposure causes TDS in humans, merely that the 
administration of very high doses of DBP to pregnant rats induces a TDS-like syndrome in 
the male offspring that shows many analogous features to human TDS. It is plausible, given 
how highly conserved the pathways of fetal development are, that phthalate administration 
may disrupt some common mechanistic pathways which if altered in humans could be 
helpful in determining the pathogenesis of human TDS. In both the human syndrome and 
the rodent model, abnormal testicular development or dysgenesis is evident by the 
abnormal organisation of these tissues. In humans, histological evidence of testicular 
dysgenesis (immature seminiferous tubules with undifferentiated Sertoli cells, 
microcalcifications and Sertoli cell only (SCO) tubules, Leydig cell hyperplasia, 
morphologically distorted tubules and the presence of carcinoma in situ (CIS) cells) have 
been found in biopsies of the contralateral testes of testicular germ cell cancer patients and 
in biopsies from patients with infertility, hypospadias and cryptorchidism (Skakkebaek et 
al., 2003). These studies support the hypothesis that all of these disorders (low sperm counts,  
www.intechopen.com
 
Toxicity and Drug Testing 484 
cryptorchidism, hypospadias and testicular cancer) are associated with TDS. The in utero 
administration of DBP to rodents during the sensitive period of tissue morphogenesis 
permanently alters the testis and produces foci of testicular dysgenesis (immature 
seminiferous tubules with undifferentiated Sertoli cells, SCO tubules, Leydig cell 
hyperplasia, morphologically distorted tubules and the presence of abnormal germ cells) 
which persist in the adult animal (Fisher et al., 2003). The downstream consequences of 
altered Sertoli cell (and subsequently Leydig cell) function may be a key cause of many of 
the observed changes in both human TDS and the rat TDS-like model due to the central role 
of this cell type in driving testis morphogenesis in both rodents and humans. Several 
population studies evaluated phthalate ester exposure and semen quality. A randomized 
controlled study of men with unexplained infertility reported a negative correlation 
between seminal plasma phthalate ester concentration and sperm morphology (Rozati et al., 
2002). Environmental phthalate levels measured by urinary metabolite, were reported to be 
associated with increased DNA damage in sperm (Duty et al., 2003). The studies measuring 
phthalate levels and semen quality seem to suggest an effect on sperm morphology and 
motility, rather than on total sperm numbers. Hauser et al.,(2005) suggest a mechanism by 
which PCB exposure may extend the bioavailability of phthalate metabolites, which in turn 
adversely affect semen quality. As human exposure consists of phthalate mixtures, along 
with xenobiotics, studies designed to test or measure single phthalate esters fail to 
appropriately characterize risks associated with these chemicals.  
1.5.5 Phytoestrogens 
Phytoestrogens are nonsteroidal plant-derived compounds with potent estrogenic activity. 
There are four main groups of phytoestrogens: isoflavonoids, flavonoids, coumestans, and 
lignans. Phytoestrogens exert their action via multiple mechanisms. Phytoestrogens interact 
with both ERǂ and ERǃ, thereby inducing weak estrogenic and antiestrogenic actions 
(Kuiper et al., 1998). Coumestrol and genistein, two phytoestrogens, exhibit a higher affinity 
for ERß than for ERǂ (Whitten & Naftolin, 1998). Some phytoestrogens exert an inhibitory 
action on steroidogenic enzymes (Strauss et al., 1998). For example, isoflavonoids and 
lignans inhibit 5ǂ-reductase activity, thereby reducing the conversion of testosterone to the 
active form DHT. A number of phytoestrogens, including lignans, isoflavonoids daidzein 
and equol, enterolactone, and genistein, were found to induce SHBG production in the liver 
(Adlercreutz et al., 1987). There are few studies measuring the effects of phytoestrogens on 
semen parameters in men. The effects of short-term phytoestrogen supplementation on 
semen quality and endocrine function were examined in a group of young, healthy males. 
Subjects received 500 mg supplements containing 40 mg of phytoestrogens isoflavones 
genistein, daidzein, and glycitein daily for 2 months and donated semen and blood for 2 
months before and 4 months after supplementation (Mitchell et al., 2001). Testicular volume 
was not influenced by phytoestrogen supplementation; nor did serum E2, testosterone, FSH, 
or LH differ between the supplement-taking group and the control group who did not take 
supplements. Finally, phytoestrogen supplementation did not produce changes in seminal 
volume, sperm concentration, sperm count, and sperm motility (Mitchell et al., 2001). A case 
report described therapeutic phytoestrogen supplementation (80 mg/day for 6 months) to 
an oligospermic man, which did sufficiently improve semen parameters such that 
intrauterine insemination was performed and the couple was able to conceive (Casini et al., 
2006). To date, evidence linking dietary consumption of phytoestrogens and reduced semen 
quality is insufficient and requires further study.  
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1.5.6 Pesticides, fungicides and herbicides 
The U.S Environmental Protection Agency (EPA) defines a pesticide as “any substance or 
mixture of substances intended for preventing, destroying, repelling, or lessening the 
damage of any pest,” which may include plants, weeds, animals, insects, and fungus. Many 
epidemiological studies use the generic term pesticides to refer to a broad range of 
structurally unrelated compounds with different mechanisms of action, biological targets, 
and target pests. Epidemiological studies that evaluate the effects of these chemicals on male 
reproductive parameters often lack direct, quantitative measures of exposure. A study of 
participants from The Study for Future Families evaluated semen quality and pesticide 
exposures in male partners of pregnant women attending prenatal clinics in Missouri and 
Minnesota (Swan et al., 2003) Urinary levels of metabolites from the pesticides alachlor, 
diazinon, atrazine, and metolochlor were detected more often in men from Missouri, 
representative of the pesticides used in the agricultural practices of this state. Pesticide 
metabolites of chlorpyrifos/chlorpyrifos methyl (3,5,6-trichloropyridinol) and methyl 
parathion (4-nitrophenol) were detected more frequently in men from Minnesota. For the 
Missouri group, there was an association between low semen quality and urinary levels of 
chlorpyrifos and parathion metabolites. Further, increased levels of herbicides alachlor and 
metoachlor were associated with decreased sperm morphology and concentration. In 
contrast, there was no association between levels of any of these pesticides and their 
metabolites and semen parameters within the Minnesota group (Swan et al., 2003). A follow-
up study focused on the men from Missouri, using a nested case-control design (cases: men 
with low semen parameters; controls: men with normal parameters). Urinary levels of 
metabolites of eight currently used pesticides were measured and correlated with semen 
quality. Men with elevated metabolite levels of alachlor and atrazine (herbicides) and 
diazinon (2-isopropoxy-4-methyl-pyrimidinol insecticide) were significantly more likely to 
have poor semen quality than controls (Swan, 2006). This study provide evidence that 
environmental exposures differ between regions, even within the same country. Different 
agricultural practices will create regional variation in the amounts and types of pesticides 
used, leading to differences in biological effects. A study in male infertility patients in 
Massachusetts measured urinary metabolites of carbaryl/naphthalene and chlorpyrifos. 
Sperm concentration, motility, and, to a lesser extent, morphology were reduced in men 
with elevated exposure to carbaryl/naphthalene (as measured by urinary levels of the 
metabolite 1-naphthol) and to chlorpyrifos (as measured by urinary levels of the metabolite 
3,5,6-trichloro-2-pyridinol [TCPY]) (Meeker et al., 2004). The mechanism of action of 
carbaryl may be related to the production of reactive oxygen species (ROS) rather than 
endocrine disruption. Carbaryl produced lipid peroxidation at low concentrations, which in 
turn induced the sperm plasma membrane to lose its fluidity and integrity, thereby 
impairing sperm motility (Meeker et al., 2004). Generally, the studies reviewed here 
demonstrated a relationship between pesticide exposure and reduced semen quality. 
However, toxicology studies using animal models are essential to understand the biological 
mechanisms underlying the adverse reproductive affects caused by pesticide exposure in 
the male. 
1.5.6.1 Vinclozolin 
Vinclozolin is a dicarboximide fungicide that has two active metabolites, M1 and M2, which 
have anti-androgenic properties. In vivo and in vitro experiments demonstrate that these 
compounds act as potent androgen receptor antagonists, and administration to pregnant 
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rats results in abnormalities of androgen-regulated sexual differentiation similar to those 
induced by flutamide, e.g. reduced anogenital distance, nipple retention, hypospadias, 
undescended testes and small or absent accessory glands (Gray et al., 2001). Studies have 
tried to define the ‘sensitive window’ for exposure to vinclozolin, and have determined that 
administration to pregnant rats during gestational day (GD) 14–19 induced reproductive 
tract malformations, with treatment over GD16–17 causing the most severe malformations 
(Wolf et al., 2000). This illustrates that the whole period of male reproductive tract 
differentiation is sensitive to the effects of anti-androgens.  
1.5.6.2 Linuron 
Linuron is a urea-based herbicide which acts as a weak androgen receptor antagonist in 
vitro and in vivo, and disrupts androgen-dependent male reproductive tract development 
after gestational exposure (Gray et al., 2001). When administered to pregnant rats (GD 14–
18; 100 mg/ kg/day) the male pups displayed a reduced anogenital distance and retention 
of areolas (Gray et al., 1999). Linuron failed to induce either hypospadias or undescended 
testes, suggesting that linuron affects testosterone-but not DHT-mediated development, 
though how this occurs is not known (McIntyre et al., 2002).  
1.5.7 Tobacco smoke 
It is beyond the scope of this review to provide a detailed review of the literature on 
cigarette smoking and semen quality. However, PAH (polycyclic aromatic hydrocarbons), 
the major carcinogenic components of cigarette smoke (Vine, 1996), were found to activate 
aryl hydrocarbon receptor (AhR), suggesting that tobacco smoke may represent a chemical 
mixture with endocrine disrupting activity. There is extensive evidence demonstrating that 
exposure to tobacco smoke is associated with reduced semen quality (Vine, 1996). An 
inverse dose-dependent relationship between smoking and semen volume, total sperm 
count, and percent motile sperm was reported following a large cross-sectional study of 
2542 healthy Danish men. Sperm concentration was 19% lower in heavy smokers compared 
to non-smokers. Serum LH and testosterone were positively correlated with smoking 
(Ramlau-Hansen et al., 2007). The incidence of bilateral cryptorchidism in a sample of 
cryptorchid Danish boys was increased in children of smoking mothers. Testicular biopsies 
from boys exposed in utero/neonatal to tobacco smoke demonstrated a decreased number 
of spermatogonia and gonocytes per tubule cross section (Thorup et al., 2006). Similarly, a 
large cross-sectional European study of 889 Danish men, 221 men from Norway, 313 
Lithuanian men, and 190 men from Estonia reported reductions of sperm concentrations by 
20% in sons exposed to prenatal tobacco smoke (Jensen et al., 2004), while a separate study 
described an inverse dose-dependent association between sperm concentration and prenatal 
tobacco exposure, measured in adult sons of 522 Danish women (Jensen et al., 2005). The 
association between impaired semen quality and smoking is fairly well established (Vine, 
1996). Although epidemiological studies of male reproductive function were designed to 
avoid the confounding effects of smoking, by limiting samples to non-smokers or 
segmenting samples according to smoking status, the interaction effects of tobacco smoke, 
alcohol, and other lifestyle factors are often not considered. An important study by Robbins 
et al.,(1997) did investigate the interactions of caffeine, alcohol, and cigarette smoking on 
sperm aneuploidy, determining that incidence of sperm abnormalities decreased after 
controlling for age and other lifestyle factors. 
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1.5.8 Medications and male reproductive toxicity 
There are a variety of prescription medications that can lead to male infertility, often 
temporary but sometimes permanent. Arthritis medication, depression drugs, high blood 
pressure medication, drugs for digestive problems as well as antibiotics and cancer drugs 
are just a few of the medications that can lead to interferences with sperm production, 
sexual function and ejaculation (Nudell et al., 2002). Here is a look at some of the common 
medications and drugs that can cause a man to experience fertility problems. 
1.5.8.1 Antihypertensive 
Although most men who are treated for hypertension are older, the recent focus on the 
importance of blood pressure control has led to greater numbers of younger patients on 
antihypertensives. Many of these medications are commonly associated with erectile 
dysfunction but most do not directly affect fertility. One exception is spironolactone, which 
acts as an anti-androgen and has been associated with impaired semen quality. Calcium 
channel blockers (e.g. nifedipine) have been reported to cause reversible functional defects 
in sperm, impairing their ability to fertilize eggs without affecting sperm production or 
standard semen analysis parameters; however, not all investigators report these types of 
effects. Diuretics can affect function by decreasing penile blood flow, and beta-blockers may 
affect libido and erectile function (Benoff et al., 1994). 
1.5.8.2 Hormones 
Diethylstilbestrol (DES) was given to pregnant women in the 1950s, and reports of 
epididymal cysts and cryptorchidism (undescended testes) in males with prenatal DES 
exposure have raised concerns about fertility; however, follow-up studies on adult men with 
prenatal DES exposure have revealed no adverse effects on fertility (Wilcox et al., 1995). 
Exogenous androgens are well known to induce hypogonadotropic hypogonadism. This 
may be induced directly by testosterone supplementation or by use of synthetic anabolic 
steroids, leading to azoospermia. This hypogonadism is usually reversible but may take 3 to 
6 months, and some patients do not recover pituitary function. It is important to remember 
that testosterone replacement therapy in younger men may lead to infertility. 
Dehydroepiandrosterone (DHEA) is a natural steroid prohormone precursor of 
androsterone, testosterone, and estrogen. DHEA is commonly taken and easily available 
over the counter. Antiandrogens and estrogens can adversely affect fertility by altering the 
HPG axis or decreasing libido or erectile function, while progesterones act by decreasing 
libido or erectile function (Nudell et al., 2002).  
1.5.8.3 Antiandrogens 
Finasteride and dutasteride are antiandrogens that act by inhibiting 5-alpha-reductase. 
Finasteride has also been used to treat male-pattern baldness. These drugs increase the risk 
of low ejaculate volumes and libido, as well as cause erectile and ejaculatory dysfunction; 
however, men taking low doses of finasteride for hair loss have shown no changes in semen 
parameters (Overstreet et al., 1999). 
1.5.8.4 Antibiotics 
Many antibiotics have been reported to exert adverse effects on male fertility; however, 
there are few human data on the majority of these medications. High doses of nitrofurantoin 
have been reported to cause early maturation arrest at the primary spermatocyte stage but 
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the more common short-term low-dose therapy is not likely detrimental. While in vitro data 
on erythromycin, tetracycline, and gentamycin suggest the potential for adverse effects on 
fertility, documentation of an in vivo effect in humans is lacking (Hargreaves et al., 1998). 
Sulfasalazine, used in the treatment of ulcerative colitis, is well known to cause defects in 
human sperm concentration and motility. Aminoglycosides, type of antibiotics is generally 
used for serious bacterial infections, like TB, and are administered under medical 
supervision. Aminoglycosides can negatively impact sperm production while neomycin has 
been shown to reduce both sperm count and motility. Macrolides, in addition to being used 
to treat chlamydia and Legionnaires disease, macrolides are similar to penicillin and can be 
used in place of it in people with a penicillin allergy. Macrolides research has mainly 
focused on animals, where it has been found that the antibiotic can decrease sperm motility 
as well as kill off sperm. It is believed that the antibiotic produces similar results in humans 
(Schlegel et al., 1991). 
1.5.8.5 Psychotherapeutic agents 
Many psychotherapeutic agents affect male fertility by suppressing the HPG axis and 
decreasing erectile function and libido. Indeed, one of the most significant side effects of the 
antidepressants is elevation of serum prolactin, leading to significant but reversible 
suppression of spermatogenesis (Nudell et al., 2002). Psychotherapeutic agents include 
antipsychotics, tricyclic and selective serotonin reuptake inhibitor (SSRI) or selective 
norepinephrine reuptake inhibitor (SNRI) antidepressants, monoamine oxidase inhibitors 
(MAOIs), phenothiazines, and lithium. There are now large numbers of patients taking SSRI 
or SNRI medications, many of which have significant fertility effects.  
1.5.8.6 Anticancer drugs 
Doxorubicin hydrochloride, Goserelin acetate, methotrexate, or fluorouracil  all are the 
drugs used to treat various types of cancer. However, these drugs have significant side 
effects on sexual behaviour, altered fertility and sperm count (Nudell et al., 2002). 
1.5.8.6.1 Chemotherapeutic agents 
Chemotherapy for the treatment of cancer can have devastating effects on male fertility 
through the impairment of spermatogenesis; indeed, alkylating agents, antimetabolites, and 
the vinca alkaloids are all gonadotoxins. The alkylating agent, cyclophosphamide alters 
male fertility; treatment with 1-2 mg/kg for more than 4 months increases the incidence of 
azospermia and oligospermia in adult male patients (Qureshi et al., 1972). In patients with 
testicular cancer, the cumulative dose of cisplatin determines whether spermatogenesis is 
impaired irreversibly. Most patients will become azoospermic, with the majority recovering 
spermatogenesis within 4 years. The majority of Hodgkin’s disease or leukemia patients 
become azoospermic after chemotherapy; this may or may not lead to permanent sterility. 
After treatment with mitoxantrone, vincristine, vinblastine, and  prednisone combination 
therapy plus abdominal radiotherapy for Hodgkin’s disease, sperm counts and motility 
were restored to pre-treatment levels in most patients (Magelseen et al., 2006).  
1.5.8.7 Miscellaneous medications 
Cimetidine has been reported to have antiandrogenic effects that induce gynecomastia and 
decreases in sperm count. Immune modulators are commonly used but, unfortunately, clear 
human data regarding male fertility for interferon or the immunosuppressant 
mycophenolate mofetil are lacking. Although cyclosporine has been found to induce 
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impaired fertility in rats, there are no human data available (Nudell et al., 2002). Epilepsy 
has been associated with decreased testosterone levels and increased estrogen levels leading 
to reductions in libido and to erectile dysfunction. Medications used to treat epilepsy (eg, 
valproate, oxcarbazepine, and carbamazepine) may worsen hormonal abnormalities and 
have been associated with some sperm morphologic defects (Isojarvi et al., 2004).  
1.5.9 Recreational and illicit substances and male reproductive toxicity 
Heavy marijuana use has been associated with gynecomastia, decreased serum testosterone 
levels, decreased sperm concentration, and pyospermia (white cells in the semen indicating 
possible infection) (Close et al., 1990). Patients experience variable sensitivity to marijuana, 
and it may take 2 to 3 months for symptoms to improve.  
Oligospermia (abnormally low sperm concentration in the ejaculate) and defects in sperm 
morphology and motility have been reported in users of cocaine. Opiates have also been 
shown to decrease libido and erectile function through induction of hypogonadotropic 
hypogonadism. This also is important to note when prescribing opioids for pain. Chronic 
opioid use whether, oral or intrathecal, may lead to sexual dysfunction (Bracken et al., 1990). 
Cumulative evidence suggests that cigarette smoking may have a deleterious effect on male 
fertility by reducing sperm production, motility, and morphology. Cigarette smoking may 
also lead to development of pyospermia, decreased sperm penetration, and hormonal 
alterations (Nudell et al., 2002; Close et al., 1990). Long-term abuse of alcohol has 
detrimental effects in the HPG axis. Alcoholics exhibit significant decreases in semen 
volume, sperm count, motility, and number of morphologically normal sperm. They also 
show signs of pyospermia. Alcohol in excess can thus exert profound deleterious effects on 
all aspects of the male reproductive system. However, there is no evidence that moderate 
alcohol intake impairs male fertility (Nudell et al., 2002; Close et al., 1990).  
The examples of few chemicals which are reported to disrupt the sex hormones and/or 
damage the male in animal studies are summarized below (Woodruff et al., 2008). 
 
Common environmental 
Toxicants 
Common uses and routes of exposure The effects on male 
reproductive system 
Heavy Metals 
(Mainly cadmium, Lead 
and arsenic) 
Population exposed to cadmium and 
lead via contaminations found in 
drinking water and food, while 
occupational exposure takes place 
during mining or manufacturing of 
batteries and pigments or industrial 
activities such as smelting and refining 
metals and municipal waste 
incineration. 
a. Testicular toxicity 
b. Low sperm count and 
motility and density. 
c. Reduce male fertility 
d. Foetal toxicity and 
malformation of male 
organs. 
Volatile organic compounds
(Toluene, benzene and 
xylene) 
Mostly occupational exposure in 
industrial workers. 
a. Testicular toxicity 
b. Low sperm count and 
motility and density. 
c. Reduce male fertility 
Phthalates 
DBP = di(n)butylphthalate 
DiBP =di(iso)butylphthalate
Phthalates are a group of chemicals 
used to impart flexibility to plastic 
polyvinyl chloride (PVC) products as 
a. Testicular toxicity 
b. Reduce anogenital 
distance, hypospadias and 
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Common environmental 
Toxicants 
Common uses and routes of exposure The effects on male 
reproductive system 
BBP = benzyl butyl 
phthalate 
DEHP = di(2-
ethylhexyl)phthalate 
DPP = dipentyl phthalate 
DINP = diisononyl 
phthalate 
DCHP = dicyclohexyl 
phthalate 
 
well as in other applications, including 
pharmaceuticals, and pesticides. There 
is widespread human exposure with 
reported uses in building materials, 
household furnishings, clothing, 
cosmetics, dentures, medical tubing and 
bags, toys, modelling clay, cars, 
lubricants, waxes and cleaning 
materials. Exposure may arise via the 
air, through absorption when used on 
the skin, and through the diet. 
undescended of testes in 
immature male. 
c. Reduce male fertility 
d. Foetal toxicity and 
malformation of male 
organs.  
Paraben 
 
 
Paraben is the name given to a group 
of chemicals used as preservatives in 
cosmetics and body care products, 
including deodorants, creams and 
lotions. They are able to penetrate the 
skin 
a. Hormone mimicking 
activities 
b. Reduce synthesis of 
testosterone 
Triclosan 
 
Triclosan is an anti-bacterial and anti-
fungal chemical widely used in 
personal care products such as some 
soaps, toothpaste etc. Triclosan has 
also been added to plastic products 
such as kitchen chopping boards. 
a. Hormone mimicking 
activities 
b. Reduce synthesis of 
testosterone 
Triclocarban 
 
Triclocarban (TCC or 3,4,4’-
trichlorocarbanilide) is also used as an 
anti- bacterial in personal care 
products such as soaps. 
a. It has sex hormone 
disrupting properties. 
 
BPA 
(Bisphenol A) 
 
BPA is the building block of 
polycarbonate plastic used in baby 
bottles, CDs, motor cycle windshields 
etc. It is also used for the production of 
epoxy resins used in the coating of the 
food packaging.  
a. Oestrogenic activities 
b. Altered male 
reproductive organs and 
induce early puberty  
c. Anti androgenic activity. 
Penta-BDE 
(Penta-brominated  
diphenyl ether) 
 
There are actually 3 commercial PBDE 
products, which predominantly 
contain deca, octa and penta-BDEs, 
and are therefore called by these 
names. PBDEs are used as flame 
retardants to prevent fire taking hold 
quickly. Penta-BDE is used in 
polyurethane foam, for example, in 
mattresses and car and aeroplane 
seats. Apart from exposure via dust it 
is possible to transfer from hand to 
mouth. 
a. Altered male 
reproductive organs  
c. Anti androgenic 
properties. 
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Common environmental 
Toxicants 
Common uses and routes of exposure The effects on male 
reproductive system 
PCBs 
 
PCBs are used in a variety of 
applications, including electrical 
applications, dielectric fluids for 
transformers and capacitors, hydraulic 
and heat transfer systems, lubricants, 
gasket sealers, paints, fluorescent 
lights, plasticizers, adhesives, 
carbonless copying paper, flame 
retardants, and brake linings. Human 
exposure also arises due to 
contamination of the food chain. 
a. Hormone mimicking 
activities 
 b. Anti androgenic 
properties. 
Dioxins 
 
Dioxins are a group of chemicals 
which are not intentionally produced, 
but are emitted during incomplete or 
relatively low temperature 
combustion. They can come from 
industrial or domestic sources, 
wherever a chlorine source is present. 
Such sources include, for example, 
domestic bonfires with PVC plastic, 
incinerators, certain chemical and 
metal factories (particularly 
aluminium recovery sites), paper pulp 
production using chlorine, and coal 
burning in power stations and in fire-
places in the home. Exposure can arise 
from inhalation, but mainly comes 
from contamination of food. 
a. Sex hormone disruptor 
b. Testicular dysfunctions 
c. Low sperm count 
d. Sperm abnormalities 
Diesel fuel Exhaust 
 
As diesel is used as a fuel in many cars 
and lorries, diesel exhaust is 
widespread. 
 
a. Disrupts androgen action 
b. Prenatal exposure in 
animals leads to endocrine 
disruption after birth and 
suppresses testicular 
function in male rats. 
Tobacco smoke 
(Polycyclic aromatic 
hydrocarbons (PAH)  
It includes active or passive smoking a. Blocks androgen 
synthesis 
b. Testicular dysfunctions 
   c. Low sperm count 
d. Sperm abnormalities 
Alkylphenols 
Nonylphenol 
Octylphenol 
 
Nonylphenol is the breakdown 
product of the surface active agent, 
nonylphenol ethoxylate. Many uses 
including in domestic cleaning and 
industrial and institutional cleaning, 
and in textiles and leather processing. 
Octyl phenol is used in the production 
a. Hormone mimicking 
activities 
b. Reduce synthesis of 
testosterone 
c. Reduce testicular size 
d. reduce male fertility and 
sperm number and quality. 
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Common environmental 
Toxicants 
Common uses and routes of exposure The effects on male 
reproductive system 
of phenol/ formaldehyde resins 
(Bakelite) and in the production of 
octylphenol ethoxylates, and used in 
the formulation of printing inks and in 
tyre manufacture 
DDT 
(break-down product DDE).
 
DDT is an insecticide which was used 
extensively on crops, but is now only 
used in a few countries against the 
malaria-bearing mosquito. DDT and 
DDE last in the soil for a very long 
time, potentially for hundreds of years. 
Unfortunately, due to this persistence, 
it is still found in some produce, such 
as vegetables, fish and liver. DDE is 
also found as a persistent contaminant 
in our bodies. The DDT breakdown 
product or metabolite, p,p’-DDE, is 
able to block testosterone. 
a. Hormone mimicking 
activities 
b. Reduce synthesis of 
testosterone 
 
Linuron 
Diuron 
Linuron and diuron are herbicide used 
to control weeds on hard surfaces such 
as roads, railway tracks and in crops 
and forestry. It has been detected in 
tap water and as a residue in 
vagetables such as carrots, parsnips 
and spinach. 
a. Anti-androgenic 
properties 
Vinclozolin 
Procymidone 
Iprodione 
Prochloroz 
Fenarimol 
 
These are all fungicide used on fruits 
and vegetables.  
a. Blocks testosterone action 
b. Reduce testosterone 
synthesis 
c. Anti-androgenic 
properties 
d. Feminize male offspring. 
Fenarimol 
Fenitrothion 
Chlorpyrifos-methyl 
 
These are all insecticides are used, for 
example, on apples, plums, barries, 
peas, sweet corn and cereals. Those 
have been found as a contaminant of 
fruit, such as oranges and grapes etc. 
a. Blocks testosterone action 
b. Reduce testosterone 
synthesis 
c. Anti-androgenic 
properties 
Ketoconazole 
 
Ketoconazole is as an anti-fungal 
product in pharmaceuticals to treat 
fungal infections of the skin. 
a. Blocks testosterone action 
b. Reduce testosterone 
synthesis 
Pyrethroid pesticides 
Permethrin 
Beta-cyfluthrin 
Cypermethrin 
Some pyrethroid pesticides such as 
Permethrin 
beta-cyfluthrin,  cypermethrin,  are 
still in use, with for example, the latter 
found as a residue in apples, beans, 
melons and oranges 
a. Blocks testosterone action 
b. Reduce testosterone 
synthesis 
c. Anti-androgenic 
properties 
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Common environmental 
Toxicants 
Common uses and routes of exposure The effects on male 
reproductive system 
Certain sun-screens 
4-MBC 
3-BC 
 
A few ultraviolet (UV) filters have 
been found as contaminants in waste 
water treatment plants and rivers. 
a. Estrogenic activity 
b. Anti-androgenic activity 
c. Interfere male sexual 
activity 
d. delay male puberty 
e. reduce reproductive 
organ weights in male 
offspring.
Heat, Ionizing radiation, 
Non-ionizing radiation, 
microwaves, 
electromagnetic fields 
Mostly occupational exposures in 
home or industry as well as the mobile 
phone users.  
a. Testicular toxicity 
b. Low sperm count and 
motility and density. 
c. Reduce male fertility 
d. Azospermia 
Chemotherapeutic drugs 
(Cisplatin, 
cyclophosphamide, 
procarbazine, and 
doxirubicine, and 
vincristine etc.) 
Anticancer treatment. a. Testicular dysfunctions 
b. Low sperm count and 
motility and density. 
c. Infertility 
d. Azospermia and 
oligospermia. 
2. Identifying hazards 
A discrepancy exists between the number of chemicals in commerce (approximately 84,000) 
and the number that have been evaluated in model species for reproductive toxicity 
potential (4,000) (U.S. EPA 1998a and 1998b). It is not feasible to allocate additional 
resources to test the 80,000 or so untested chemicals through traditional testing protocols, 
particularly given that about 2,000 new chemicals are introduced into commerce each year 
(U.S. EPA 1998). Instead, new, more rapid methods are needed to screen large numbers of 
chemicals and to identify those that are potential reproductive hazards. In the near term, top 
priorities will be to develop the most promising alternative models and to test their ability to 
appropriately classify the toxicity of sets of known toxicants and non-toxicants.  
2.1 High-throughput assays 
High-throughput assays evaluate the effect of a test substance on a single biologic process 
using an automated manner that allows thousands or tens of thousands of compounds to be 
tested in a short time at a reasonable cost. Robotics and genetic engineering make it possible 
to produce large quantities of receptors or genetically engineered cells for use in these 
assays. Knowledge about mechanisms of toxicity is often central to the strategy of high-
throughput assays. For example, cells are being developed that are bioengineered to express 
human hormone receptors for estrogens and androgens. These cells can be used for high-
throughput chemical screening for steroid hormone receptor affinity or the potential to act 
as endocrine disruptors. Both isoforms of recombinant human estrogen receptor and human 
androgen receptor are commercially available for this purpose. Based on the same 
principles, other batteries of high-throughput assays are available to screen for activity 
against various receptors and cytochrome P-450 enzyme isoforms (Lawson et al., 2003). The 
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availability and application of these assays will undoubtedly expand as we understand 
more about the relevance of each protein in toxicologic processes. 
2.2 Structure-activity prediction 
Methods for predicting activity from structure continue to be developed and refined. 
Computer programs use available empirical information about the toxicity of existing 
compounds and their chemical characteristics to predict whether a new compound will have 
similar toxicity. These programs have not performed well in the area of reproductive and 
developmental toxicity, probably because reproductive processes are complex and effects 
may be elicited through multiple modes and mechanisms. As science progresses and we 
learn more about mechanisms of toxicity at the molecular level, however, structure-activity 
computer programs will become more exact and predictive. The best examples are the 
programs that are being developed and refined for estrogen receptor binding (Tong et al., 
1997). 
2.3 Integration of human studies and tests of model species 
Though 4,000 chemicals have been tested in model species, few chemicals have been 
adequately evaluated for reproductive effects in humans and contain a partial list of known 
human developmental and adult toxicants. Because the interpretation of studies of model 
species is often not straightforward and because field studies are labor and resource 
intensive, a systematic approach is needed to select and prioritize chemicals for 
epidemiologic studies. Moorman et al., (2000) recently proposed a process for selecting 
chemicals for human field studies. In this process, information gained from model species 
testing conducted by the National Toxicology Program (NTP) was reviewed for significant 
adverse reproductive effects and potency of the toxicants. The evaluative process then 
combined this information with human exposure information available in public databases 
to arrive at a list of high-priority candidates for studies in humans.  
2.4 New biomarkers for humans and model species 
In 1977, men exposed to dibromochloropropane (DBCP), a pesticide that is now banned in 
the United States, were found to be azoospermic and oligospermic (Whorton et al., 1977). 
Currently, a variety of biomarkers are used to assess the potential adverse reproductive 
effects due to toxic chemical exposures. Bioindicators of sperm production and quality 
(semen volume, sperm concentration, sperm motility, sperm morphology) are routinely 
evaluated in ejaculated semen samples in men and in suspensions of epididymal sperm 
from test species (epididymal sperm reserves, sperm motility, and sperm morphology) 
(Moline et al., 2000; U.S. EPA 1998a). During the past decade, computer-assisted methods 
developed to improve and automate the evaluation of sperm motion and morphology have 
been added to the battery of routine sperm measures, and guidance for their use and 
interpretation has been made available through a number of workshops (ILSI 1999; Seed et 
al.,1996). Furthermore, baseline data on the relationship between various semen or 
epididymal sperm measures and fertility have emerged from a number of large studies 
designed to address this question (Zinaman et al.,2000). Thus, these measures are widely 
accepted biomarkers of adverse reproductive effects that are suitable for application in both 
human and model species studies. Serum hormone measures can also be determined in 
humans and test species. Inhibin B has been proposed as an indicator of testicular function 
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and a possible surrogate for sperm measures (Anderson and Sharpe 2000). The recognition 
that sperm functional tests are also desirable has led to development of various new tests 
that have only recently been applied to toxicology. Biomarkers of the genetic integrity of 
sperm are designed to identify risks for paternally mediated developmental effects. Sperm 
proteins are being tested as biomarkers of fertility to detect specific deficits in sperm 
function (as opposed to decreased sperm output). Although details of such tests are beyond 
the scope of this review, Table 1. provides a list of new tests and references regarding 
methodology and examples of use. Further research is needed to make these tests more 
practical and more cost effective and to determine their ultimate utility for hazard 
identification and elucidation of modes and mechanisms of toxicant action. 
 
Target                                          Bioassay                                       Function assessed 
 
Sperm fertilizing ability 
SP-22 protein 
Sperm antigens 
Ubiquitin 
Sperm function 
Acrosome reaction 
Sperm maturity 
Cytoplasmic droplets 
Heat shock protein A2 
Sperm morphology 
Sperm DNA 
CMA3 staining 
COMET 
DNA adducts 
TUNEL 
SCSA 
Chromatin damage 
DNA damage 
Sperm chromosomes FISH 
Aneuploidy, Brakage 
Translocation 
Sperm count surrogate Inhibin-B 
Endocrine feedback of 
spermatogenesis. 
 
Abbreviations: CMA3 staining, Chromomycin A3 staining; COMET, Single-cell gel electrophoresis 
assay; FISH, Fluorescence in situ hybridization; SCSA, Sperm chromatin structure assay; TUNEL, 
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin end-labeling (Lawson et al., 2003) 
Table 1. The Biomarkers for the assessment of male reproductive toxicity by Chemical 
agents (Lawson et al., 2003). 
2.5 Estimating occupational exposure 
Establishing that a significant number of workers or members of the general population are 
or will be exposed to a potential reproductive toxicant is central to priority setting. NIOSH's 
National Occupational Hazard Survey and National Occupational Exposure Survey 
conducted in 1972-1974 and 1981-1983, respectively, has been used extensively to identify 
substances of common exposure (NIOSH 1978, 1988). These surveys are the only 
comprehensive assessments of general industry where the number of workers potentially 
exposed to chemical agents has been estimated. However, these databases are outdated and 
of limited use because they indicate only potential exposure. NIOSH is currently planning a 
new hazard surveillance activity that will target industry sectors on a rolling basis, 
beginning with the health care sector. Public health researchers will continue to require 
updated exposure surveys to keep up with the changing workplace exposures and monitor 
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new exposures that may be potential reproductive toxicants. New technologies such as 
geographic information systems (GIS) allow mapping of industries and specific chemical 
exposures. Use of GIS to identify geographic areas with high volume of use of suspect 
chemicals might be an effective method of identifying populations with greater potential 
occupational and environmental exposures. Biomonitoring is a valuable tool for estimating 
occupational exposure. The National Report on Human Exposure to Environmental 
Chemicals is a new and ongoing assessment of the U.S. population's exposure to 
environmental chemicals. The first edition of the report presents levels of 27 environmental 
chemicals, including metals (e.g., lead, mercury, and uranium), cotinine (a marker of tobacco 
smoke exposure), organophosphate pesticide metabolites, and phthalate metabolites. This is 
a significant step forward in assessing the potential human toxicity of a class of chemicals 
known to be reproductive and developmental toxicants in rodents. Improved methods for 
analysis of exposure, especially of age and time effects, are likely to impact the 
characterization of occupational exposure in these studies (Richardson and Wing 1998). 
Current research approaches usually consider the action of single, unique toxicants on 
outcomes of interest, creating yet another challenge to drafting a reproductive hazards 
agenda. The more common human exposure scenario is to mixtures of toxicants at low 
concentrations, episodically and over the long term. Attention to cumulative exposure over 
years of a working lifetime and total aggregate exposure to toxicants from multiple 
exposure sources, as well as classical considerations of exposure routes, must also be 
addressed. Methodologic approaches must enlarge and mature to consider the effects and 
modulation of effects mediated by both exposure to mixtures of toxicants and the 
complexities of exposure mode at low dose and over prolonged duration. 
2.6 Mechanistic research 
Understanding mechanisms of action of toxicants is important for a number of reasons, 
including a) supporting the biologic plausibility of an observed association between 
chemical exposure and adverse outcome; b) uncovering common pathways of actions of 
different agents; c) extrapolating across species for risk assessment; d) improving the 
predictability of human morbidity from responses of model species; and e) predicting 
responses to mixed exposures (Lawson et al., 2003). Mechanistic studies are not new in 
toxicology; however, new tools in genomics, proteomics, and bioinformatics present 
unprecedented opportunities to advance our understanding of toxicant action at a molecular 
level. Genomic information and the ability to screen most or all of the genome of an 
increasing number of organisms for changes in gene expression are revolutionizing the way 
in which biologic effects data are gathered. It is now possible to determine the effects of a 
toxicant exposure on gene expression of most of the genome of mice and rats. This will 
allow us to generate testable hypotheses about the mechanism of action of toxicants. It will 
also open up the possibility of identifying markers of exposure or effect specific to a 
particular insult that can be used in field studies. As with any new technology, a number of 
problems will need to be overcome for the promise of genomics to be realized. The first will 
be to manage the large volume of information produced by gene expression experiments. 
Gene chips may contain thousands or tens of thousands of sequences. Experience shows 
that any perturbation in a biologic system leads to numerous changes in gene expression. 
An entire field of bioinformatics is being developed to help collect, organize, and manage 
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the data to identify changes related temporally, by dose, or by metabolic pathway. The 
second challenge will be to separate those changes in gene expression pivotal to the toxic 
response from those that are more generalized responses to any stimulus. The third 
challenge will be to quantitatively relate changes in expression of critical genes with toxicity, 
which is manifested at a more complex level of biologic organization (i.e., the cell, organ, or 
organism). Real comfort in this genomic approach will come only with experience and the 
development of a large database.  
2.7 Gene-environment interactions 
Reproductive toxicants can affect human populations over the total life span, including the 
in utero and perinatal periods, childhood, puberty, and adulthood. Thus, extending research 
efforts to address stage-specific sensitivity is recommended. Another emerging approach 
allows the identification of populations at potentially increased risk from toxicant exposure 
by characterizing genetic polymorphisms of metabolizing enzymes in exposed cohorts. Such 
methods may identify vulnerable subpopulations on the basis of inherent (genetic) 
differences in their ability to metabolize a toxicant. 
2.8 Identifying genes that increase sensitivity to reproductive toxicants 
Genetic factors that elevate risk for disease can be grouped into two categories: those for 
which having a particular allele conveys a high risk for the disease regardless of other (e.g., 
environmental) influences and those associated with only small increases in risk of the 
disease. The latter, termed susceptibility genes are being identified at an increasing rate. The 
interaction of these alleles with environmental agents or other susceptibility alleles 
ultimately determines whether the disease will be manifested. Much work has been done to 
understand the role of these genes for reproductive toxicity. 
2.9 Potential information from genetics to advance epidemiologic studies 
If epidemiologic studies could identify genetic-toxicant interactions by comparing the 
prevalence of a particular genetic marker (polymorphism) or a group of markers in affected 
and unaffected populations, this information could be used to target environmental, 
behavioral, or medical interventions (Khoury 1997). Ultimately, validation of genetic testing 
to link a particular genotype with exposure to a specific chemical to the increased 
prevalence of a particular reproductive disorder would require epidemiologic confirmation 
(Khoury & Dorman 1998).  
2.10 Communication 
An essential component of future reproductive studies will be improved communication. 
Because of the complex mechanisms involved in reproductive research, collaboration across 
scientific disciplines must be conducted. In addition, notification of research results and 
recommendations must be communicated to workers and the affected public in a manner 
that is timely, accessible, and easily understood. A primary goal of reproductive research is 
to reduce the high percentages of adverse outcomes such as infertility, pregnancy loss, and 
congenital malformations. Although certain limitations exist that are unique to reproductive 
research, many advances in technology and methodologies have been recently developed 
that will aid researchers in their efforts to a) understand mechanisms by which toxicants 
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exert their effects, b) identify populations at risk, and c) evaluate reproductive and 
developmental hazards to improve public health. 
3. Methods of assessing male reproductive capacity 
The determination of sperm concentration, morphology, and motility remains the primary 
clinical assay for male infertility (WHO, 1999). The WHO guidelines on semen quality 
provide reference semen parameters as follows: sperm concentration >20 million/ml, 50% 
motility, and at least 50% normal morphology (WHO, 1999). Oligospermia is the term for 
semen with <20 million/ml sperm in ejaculate, and asthenospermia for semen with sperm 
<50% motility or <25% rapid progressive motility, teratospermia for reduced percent sperm 
with normal morphology, and azoospermia for the absence of sperm in the ejaculate (Braude 
& Rowell, 2003). It is unknown whether endocrine disrupter exposure represents a subset of 
the environmental risk factors for male infertility, as there are few studies that examine 
exposure and human semen quality. Moreover, toxicants can affect the male reproductive 
system at one of several sites or at multiple sites. These sites include the testes, the accessory 
sex glands, and the central nervous system, including the neuroendocrine system.  
3.1 The contribution of experimental models  
The usefulness of experimental animal models is usually perceived as limited to hazard 
identification using the test protocols specified by regulatory agencies. However, animal 
models can also provide valuable support to reproductive risk assessment on many other 
fronts. If the focus is on human exposure, animal studies can be designed to confirm 
reproductive toxicity when initial observations in exposed humans are suggestive of an 
adverse effect. Furthermore, such observations can be extended across a wide range of 
exposures in animals, using any route of exposure and any specified dose versus time 
scenario. For example, when human exposure is likely to be acute or intermittent, animal 
models are ideal for defining critical exposure windows based on developmental stage or 
for revealing the pathogenesis of an effect at various times after exposure through recovery. 
This is particularly important with respect to male reproductive effects because alterations 
in semen quality or fertility may not become evident until sometime after the exposure, 
particularly if an early stage of spermatogenesis is targeted. A rodent model is most 
commonly used for the study of reproductive and developmental toxicity (Claudio et al., 
1999). To use toxicology data derived from animal studies to advantage in risk assessment, it 
is critical to identify and understand species-specific differences in physiology and 
metabolism that may affect the response to the toxicant in question. Rodent models have, for 
example, been used to determine the relationship between sperm end points and function 
(fertility) (Chapin et al., 1997). Determining that a substance is toxic to the male reproductive 
system is only the first step: The next step is to examine its mechanisms of toxicity. 
Mechanistic information allows for predictions about the potential toxicity of individual 
compounds or complex mixtures in humans, for better understanding of the windows of 
vulnerability in the development of the male reproductive system, and for developments of 
possible preventive or curative measures. Acute short-term exposure models combined with 
serial exposure models give a complete picture of the range of effects (Claudio et al., 1999). 
Exposing animals over a long period of time allows for the detection of transgenerational 
effects from chemicals, such as male-mediated developmental effects. If developmental 
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effects appear, researchers can go back and administer a dose during that critical period of 
development to refine knowledge about how such problems occur. Early developmental 
end points measurable in animal research include anogenital distance at birth, testis 
position, genital malformations, secondary sex characteristics, and serum hormone levels. 
Acute short-term exposures, on the other hand, can be useful for identifying critical 
windows of exposure. Acute exposures followed over time can help identify the 
pathogenesis of a lesion, isolate the cell type that is susceptible to damage (germ cells, 
spermatocytes, or spermatid), and determine genetic effects, including the repair capability 
of affected genes. Serial sacrifice studies are best used for identifying the earliest detectable 
pathologic changes in target organs, cells, or processes. Multigeneration studies, in 
particular continuous breeding studies, yield the most thorough assessment of the many 
complex processes that result in reproductive and developmental toxicity. 
3.2 Epidemiologic approaches  
Epidemiologic methods for assessing the impact of hazardous substances on male 
reproductive health include a) questionnaires to determine reproductive history and sexual 
function, b) reproductive hormone profiles, and c) semen analysis. The choice of appropriate 
methodologies to study the effects of reproductive toxicants is predicated on the investigators' 
understanding of several factors: the nature of the exposed population; the source, the levels, 
and the known routes of exposure; the organ systems in which a toxicant exerts its actions; the 
hypothesized mechanisms of a toxicant's actions; and the techniques available to assess the 
effects of toxicants in the relevant organ systems (Wyrobeck et al., 1997). Table 2 outlines the 
methods currently available for assessing the principal targets of male reproductive toxicants 
in humans--the testes, the accessory sex glands, the neuroendocrine system, and sexual 
function. Researchers and clinicians interested in male reproductive health and fertility are 
using increasingly sophisticated methods adapted from the fields of assisted reproductive 
technology and reproductive toxicology, including assays of sperm function, genetic integrity, 
and biomarkers of DNA damage. For population-based studies involving occupational groups 
or communities with environmental exposures, issues related to the cost, validity, precision, 
and utility of these methods must be carefully considered. 
The testis, the site of sperm cell production and the target organ for genetic damage, is most 
often studied. To establish the extent of toxicity to the testis, researchers can measure the 
size of the testis, obtain a semen sample, or take a testicular biopsy. Standard semen 
analyses (including semen volume, sperm concentration, total sperm count, motility, and 
morphology) have been the primary research tools for studying the effects of toxicants on 
the male reproductive system. Epidemiologic studies have successfully utilized semen 
quality as a marker of fertility (Fisch et al., 1997). The uncertainties associated with 
traditional semen measures have led to the recent development of assays of sperm function 
and genetic integrity; these assays may prove more sensitive and more specific reflections of 
toxicant-induced effects (e.g., aneuploidy or reduced sperm motility) in individuals (Martin 
et al., 1997). However, The accessory sex glands, which include the epididymis, prostate, 
and seminal vesicle, may also be targets of toxicants (Schrader, 1997). Ethylene dibromide is 
one substance that affects the accessory sex glands after occupational exposure. Alterations 
in sperm viability, as measured by eosin stain exclusion or by hypo-osmotic swelling or 
alterations in sperm motility variables, suggest a problem with the accessory sex glands. 
Biochemical analysis of seminal plasma provides insights into glandular function by  
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Sl. No. Methods of Assessment: 
 
1. Testosterone (T) , Prolactin, LH, FSH, and Inhibin-B concentrations. 
2. Semen volume and pH.  
3. Sperm density/Sperm count. 
4. Sperm morphology and morphometry 
5. Sperm motility (% of motile  and velocity), Sperm viability (Vital stain and 
Hyper Osmotic Swelling (HOS)).  
6. Sperm function assays (Acrosome reaction, Hemizona assay of sperm binding
and sperm penetration assay). 
7. Sperm genetic analysis (Sperm chromatin stability assay, Comet assay.
Assessment of chromosomal aneuploidy and Nuclear microdeletions). 
8. Marker chemicals from accessory glands (Epididymis is represented by glyceryl-
phosphorylcholine, Seminal vesicles by fructose, and the Prostate gland by zinc). 
9. Nocturnal penile measurements. 
10. Personal reproductive history (Pubertal development, Paternity (Pregnancy
timing and outcomes), Sexual functions (Erection, Ejaculation, Orgasm and
Libido)).  
Table 2. Assessment of Male Reproductive Capacity in Humans (Moline et al., 2000). 
evaluating marker chemicals secreted by each respective gland (Schrader, 1997). For 
example, the epididymis is represented by glycerylphosphorylcholine, the seminal vesicles 
by fructose, and the prostate gland by zinc. Measures of semen pH and volume provide 
additional general information on the nature of seminal plasma, reflecting post testicular 
effects. A toxicant or its metabolite may act directly on accessory sex glands to alter the 
quantity or quality of their secretions. Alternatively, the toxicant may enter the seminal 
plasma and affect the sperm or may be carried to the site of fertilization by the sperm and 
affect the ova or conceptus. The presence of toxicants or their metabolites in seminal plasma 
can be analyzed using atomic absorption spectrophotometry or gas chromotography/mass 
spectrometry. Impact on the neuroendocrine system is another mechanism whereby 
toxicants can disturb the male reproductive system. To establish the extent of endocrine 
dysfunction, hormone levels can be measured in blood and urine. The profile recommended 
by NIOSH to evaluate endocrine dysfunction associated with reproductive toxicity consists 
of assessing serum concentrations of follicle-stimulating hormone (FSH), luteinizing 
hormone (LH), testosterone, and prolactin (Schrader, 1997). Because of the pulsatile 
secretion of LH, testosterone, and to a much lesser extent FSH, and the variability in the 
evaluation of reproductive hormones, it is recommended that three blood samples be drawn 
at set intervals in the early morning and the results pooled or averaged for clinical 
assessment. In epidemiologic field studies, however, multiple blood samples are impractical 
and may decrease participation rates. Alternatively, LH and FSH can be measured in urine, 
providing indices of gonadotropin levels that are relatively unaffected by pulsatile secretion. 
However, if an exposure can affect hepatic metabolism of sex steroid hormones (Apostoli et 
al., 1996), urinary measures of excreted testosterone metabolite (androsterone) or estradiol 
metabolite (estrone-3-glucuronide) are not recommended. Moreover, future assessment of 
reproductive hormones may extend to inhibin, activin, and follistatin, polypeptides that are 
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secreted primarily by the gonads and that act on the pituitary to increase (activin) or 
decrease (inhibin and follistatin) FSH synthesis and secretion. Within the gonads, these 
peptides regulate steroid hormone synthesis and may also directly affect spermatogenesis. 
Ongoing studies are investigating the utility of serum inhibin-B level as an important 
marker of Sertoli cell function and in utero developmental toxicity (Jensen et al., 1997). Other 
indicators of central nervous system toxicity are reported alterations in sexual function, 
including libido, erection, and ejaculation. There is not much literature on occupational 
exposures causing sexual dysfunction in men (Schrader, 1997); however, there are 
suggestions that lead, carbon disulfide, stilbene, and cadmium can affect sexual function. 
These outcomes are difficult to measure because of the absence of objective measures and 
because sexual dysfunction can be attributed to and affected by psychologic or physiologic 
factors (Schrader, 1997). 
3.3 Biomarkers of genetic damage 
Biomarkers of chromosomal and genetic damage are increasingly used in the search to 
understand abnormal reproductive health outcomes, in part because of the possibility that 
there may be identifiable genetic polymorphisms which make an individual more 
susceptible to the adverse reproductive effects from exogenous substances. These assays 
provide promising and sensitive approaches for investigating germinal and potentially 
heritable effects of exposures to agents and for confirming epidemiologic observations on 
smaller numbers of individuals. Efficient technology for examining chromosomal 
abnormalities in sperm has only been developed recently. Chromosomal abnormalities are 
primarily of two types: numerical and structural. Both kinds can be attributed in some cases 
to paternal factors. Karyotype studies have shown that although oocytes demonstrate a 
higher frequency of numerical chromosomal abnormalities, human sperm demonstrate a 
higher frequency of structural abnormalities with less frequent numerical abnormalities 
(Moosani et al., 1995). In assessing sperm exposure to toxicants, it is therefore imperative to 
assess DNA structural integrity and not just chromosomal count. Aneuploidy is a 
chromosomal abnormality that causes pregnancy loss, perinatal death, congenital defects, 
and mental retardation. Aneuploidy, a disorder of chromosome count, is observed in 
approximately 1 in 300 newborns. It is speculated that of all species, humans experience the 
highest frequency of aneuploidy at conception, with estimates ranging from 20 to 50% 
(Moosani et al., 1995). Spontaneous abortions occur in at least 10-15% of all clinically 
recognized pregnancies. Of these, 35% contain chromosomal aneuploidy. Despite such a 
high frequency, there is little information about what causes this abnormality in humans. 
Paternal origins of aneuploidy and other genetic abnormalities can be analyzed by studying 
chromosome complements in human sperm. Two types of analyses provide data on 
chromosomal abnormalities in human sperm: sperm karyotype analysis and fluorescence in 
situ hybridization (FISH) (Moosani et al., 1995). Each technique has advantages and 
disadvantages. Sperm karyotyping is performed after sperm have fused with hamster 
oocytes. It provides precise information on numerical and gross structural abnormalities of 
all chromosomes from a given spermatozoon. However, only a limited number of sperm can 
be evaluated in each assay, and only those sperm that fertilize the oocytes are analyzable. 
Furthermore, this assay is technically difficult, labor intensive, expensive, and requires the 
use of animals. Also, it is better suited for clinical than for field studies because it must be 
performed on fresh semen. FISH, on the other hand, relies on the use of chromosome-
specific probes to detect extra chromosomes (aneuploidy) or chromosome breaks or 
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rearrangements in sperm. It is performed directly on sperm cells, eliminating the need for 
the use of animals. Although information is gained only for several chromosomes at a time, 
slides can be reprobed to increase the number of chromosomes evaluated. Furthermore, 
FISH can be conducted on archived sperm (either frozen or dried on slides), making it ideal 
for use in field studies. However, because the incidence of sperm aneuploidy is low, many 
cells (up to 10,000 per semen sample) must be evaluated, which requires significant scoring 
times. In comparison to karyotype analysis, however, FISH is relatively inexpensive and 
technically simpler, and data are obtained on all sperm, not just the ones that are capable of 
fertilization. These two techniques complement each other, with FISH providing 
information on large numbers of cells and karyotyping providing more precise and detailed 
information (Robbins et al., 1997). 
3.4 Develop biomarkers of exposures and male reproductive health for research and 
clinical use 
Resources must be invested in developing more advanced biomarkers of exposure to 
reproductive toxicants and of male reproductive health outcomes. Advanced biomarkers 
would allow for the development of toxicant-specific tests (e.g., polycyclic aromatic 
hydrocarbon-DNA adducts) and the detection of subclinical changes that might have 
significant health implications but which now go unnoticed by current measures. New 
biomarkers of semen quality are advantageous in that they can both describe male 
reproductive capacity and indicate toxic effects independent of the female partner's 
reproductive health. New tests could more accurately measure sperm function, fertilization 
potential, and the transmission of an intact male genome. Genetic testing may provide 
valuable tools for researchers and clinicians. For example, the sperm chromatin stability 
assay and FISH are used to assess genetic structure after exposure to a potential toxicant. 
Recently, single nucleotide polymorphisms have been used in the assessment of gene-
environment interactions. 
4. Mechanism of male reproductive toxicity 
The disruption of spermatogenesis may be represented by four mechanisms, including (1) 
epigenetic changes to the genome, (2) apoptosis of germ cells, (3) dysregulation of 
androgenic signaling, and (4) disruption of Sertoli and other spermatogenesis support 
(Phillips & Tanphaichitr, 2008) (Figure 4). The first mechanism is relatively novel and was 
only demonstrated in vitro by one group thus far. Rats exposed in vitro to anti-androgenic 
pesticides vinclozolin or methoxychlor demonstrated heritable changes in methylation 
status of genomic DNA. These epigenetic effects included impaired male fertility and were 
evident in the F3 and F4 generations (Anway et al., 2005). Reduced sperm number or altered 
sperm morphology may be indicative of problems during spermatogenesis and 
spermiogenesis and may be produced by the direct loss of developing spermatocytes. Adult 
rats exposed in utero to flutamide, an antiandrogen, exhibit hypo-spermatogenesis 
associated with increased apoptosis of adult germ cells (Maire et al., 2005). Anti-androgenic 
exposure is associated with elevation of pro-apoptotic molecules, including Fas-L (Maire et 
al., 2005), caspase-3 and caspase-6, Bax, Bak, and Bid, and a decrease in anti-apoptotic 
molecules Bcl2 and Bclw (Bozec et al., 2004) in rat models. Di(2-ethylhexyl) phthalate 
(DEHP) exposure in rats induces testicular apoptosis via a mechanism involving ERK1/2-
induced up-regulation of PPAR (peroxisome proliferators-activated receptor) -Ǆ, RXR   
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Fig. 4. Possible Pathways of endocrine disruption by environmental chemicals. DDE= 1, 1-
dichloro-2, 2-bis (p-chlorophenyl) ethylene; DDT= dichlorodiphenyltrichloroethane; PAHs= 
polycyclic aromatic hydrocarbons; PCBs= polychlorinated biphenyls. (Modified from 
Sharpe & Irvine, BMJ, 2004). 
(retinoid X receptor)-ǂ and p21, and down-regulation of pRB, cyclin D, CDK2, cyclin E, and 
CDK4 (Ryu et al., 2007). Neonatal estrogen treatment (DES, ethinyl estradiol [EE]) increased 
apoptosis at all stages of spermatogenesis in the rat (Atanassova et al., 1999). Thus, 
apoptosis is a likely mechanism for some mechanisms of endocrine disruption in the testis 
(Jana et al., 2010b). Testicular androgenic signalling may be impaired via several 
mechanisms, including decreased Leydig cell population, impaired Leydig cell 
steroidogenesis, and dysregulation of the HPT axis. Abnormal development and maturation 
of the Leydig cell population reduces the steroidogenic potential of the testis. In utero 
exposure to phthalate esters is associated with morphological abnormalities of the male 
reproductive tract, including decreased anogenital distance, cryptorchidism, hypospadias, 
diminished Leydig cell population, and decreased testicular testosterone (Mylchreest et al., 
2000; Fisher et al., 2003). Phthalate esters such as DEHP are proposed to exert 
antiandrogenic and estrogenic mechanisms of action and disrupt hormone synthesis via an 
AhR pathway (Ge et al., 2007). Low-dose BPA exposure in utero reduced the size of the 
epididymis and decreased anogenital distance and increased prostate size (Gupta, 2000) in 
adult mice. Leydig cell maturation and development include expression of genes related to 
endocrine signaling (LH receptors, AR) and steroidogenesis. Steroidogenesis is dependent 
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on availability of cholesterol to the cytochrome P-450 cholesterol side chain cleavage 
(P450scc) enzyme complex within the mitochondria, the rate-limiting and regulated step in 
steroidogenesis (Miller, 1988). Steroidogenic acute regulatory protein (StAR) is proposed as 
the candidate protein for the acute regulation of steroidogenesis. StAR transports cholesterol 
into the inner membrane, where steroidogenic enzymes catalyze consecutive reactions to 
convert cholesterol to testosterone in Leydig cells (Clark et al., 1994, Jana et al., 2008; 2010a; 
2010b). In utero exposure to exogenous estrogens (EE, DES, genistein, and BPA)  
downregulate expression of a number of testicular genes including Cyp17, Cyp11a, and StAR 
expression in the rat and mouse (Fielden et al., 2002). The expression of a number of genes 
related to steroidogenesis (Scarb1, Star, Cyp11a1, HSD3b1, and CYP17a1) was altered 
following in utero exposure to di(n-butyl) phthalate (Barlow et al., 2003). Testicular 
androgen signalling may also be impaired through suppression of normal HPT regulation of 
Leydig cell steroidogenesis. Disruption of the HPT axis, thereby reducing testicular 
testosterone levels, was demonstrated in the rat following exposure to a range of endocrine 
disrupters. Exposure to estrogens DES and EE also impaired HPT signalling in the rat, 
reducing plasma testosterone and increasing plasma FSH  (Atanassova et al., 1999). Both 
Leydig and Sertoli cells contain the enzyme aromatase and convert androgens to estrogens, 
thereby providing an intratesticular source of estrogens (O'Donnell et al., 2001). Atrazine, a 
herbicide with antiandrogenic and estrogenic properties, was found to produce a number of 
adverse reproductive effects in the rat. Atrazine has a low affinity for androgen and 
estrogen receptors, reduces androgen synthesis, and enhances estrogen production via the 
induction of aromatase (Sanderson et al., 2000). Thus, testicular physiology is sensitive to 
perturbations of androgenic and estrogenic signalling, such that xenobiotic exposures might 
result in reduced fertility. Sertoli cell number is directly representative of the spermatogenic 
potential of the testis. Ablation of the Sertoli cell population, or loss of Sertoli cell function, is 
therefore another mechanism by which endocrine disrupters may impair spermatogenesis. 
Exposure to prenatal DES or EE reduced adult population of Sertoli cells in rats (Atanassova 
et al., 1999) and supports the hypothesis that in utero exposure to estrogens contributes to 
impaired spermatogenesis in the adult. It is also noteworthy that human spermatogenesis is 
much less efficient than in rodents, such that small decreases in the population of Sertoli 
cells would be expected to have large effects on male fertility in human. Estrogenic 
disruption of the testis is perhaps the most well characterized example of endocrine 
disruption of spermatogenesis; however, it is also worthy to note that estrogens play 
important roles in development of hormone responsive tissue, including Leydig cells and 
development and differentiation of the fetal male reproductive tract (Tsai-Morris et al., 
1986). ERs, both alpha and beta (ERǂ and ERß), are found throughout the male reproductive 
tract and represent a transcriptional mechanism by which endocrine disrupters may alter 
gene expression. In rodents, ERǂ is expressed by all developmental stages of Leydig cells 
(fetal, neonatal/pubertal/adult), seminiferous tubules, efferent ductules, and epididymis 
but not Sertoli cells. ERß is expressed in all stages of rodent Leydig and Sertoli cell 
development and in efferent ductules and epididymis (O'Donnell et al., 2001). The existence 
of plasma membrane ERs along with the different tissue distribution, C-terminal ligand-
binding domain and N-terminal transactivation domain of ERǂ and ERß provide possible 
explanations for the differential effects of so-called weak estrogens like BPA (Wozniak et al., 
2005). These are but a few of the mechanisms by which endocrine disrupters might impair 
spermatogenesis. Other mechanisms include dysregulation of bioavailable androgens via 
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increased synthesis of sex hormone binding globulin (SHBG) and other plasma binding 
proteins (Haffner, 1996) and disruption of testicular androgen signaling by AhR ligands, 
PAH and nicotine, contained in tobacco smoke (Kizu et al., 2003) and many others. Further 
that, increasing evidence suggests an induction of oxidative stress in the testis represents 
another common response after exposure to environmental toxicants (Jana et al., 2010a & 
2010b). Increase in oxidative stress can be seen in ≤80% of clinically proven infertile men, 
and exposure to environmental toxicants is a major factor contributing to such an increase 
(Tremellen, 2008). Environmental toxicants that have been shown to induce oxidative stress 
in the testis are highly heterogeneous, with different chemical structures, and include 
cadmium (Liu et al., 2009), bisphenol A (Kabuto et al., 2004) and 2,3,7,8-tetrachlorodibenzo-
p-dioxin (Dhanabalan &  Mathur, 2009).  
Interestingly, these environmental toxicants commonly increase oxidative stress by down 
regulating the production of antioxidant enzymes such as superoxide dismutase, catalase 
and glutathione peroxidase. In turn, excessive amounts of reactive oxygen species (ROS) are 
produced. ROS damage the lipids, proteins, carbohydrates and DNA in cells (Jana et al., 
2010a & 2010b; Figure 5). Importantly, these observations were confirmed in studies 
illustrating that co-administration of antioxidants such as vitamin E with environmental 
toxicants could alleviate the pathophysiological effects (e.g. reduction in sperm count) of 
toxicants in the testis (Latchoumycandane & Mathur, 2002). These findings demonstrate that 
oxidative stress induced by environmental toxicants is one of the major contributing factors 
to male infertility. In fact, oxidative stress has long been linked to male infertility; although 
most studies have focused on its roles in causing abnormalities in germ cells and apoptosis 
(Sikka, 2001; Turner and Lysiak, 2008). Recent studies have shown that environmental 
toxicant-induced oxidative stress can cause male infertility by disrupting the cell junctions 
and adhesion between Sertoli–Sertoli cells and/or Sertoli–germ cells via the 
phosphatidylinositol 3-kinase (PI3K)/c-Src/focal adhesion kinase (FAK) signaling pathway 
(Wong & Cheng, 2011). Oxidative stress is known to increase epithelial and endothelial 
permeability by disrupting tight junctions (TJ) and adherens junctions (AJ) between cells 
(Sandoval and Witt, 2008). Activation of the PI3K/c-Src signalling pathway in response to 
oxidative stress induced by environmental toxicants could be a common mechanism by 
which the toxicants trigger damage to the testis. Early evidence shows that the toxic effects 
of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the testis are caused by an induction in c-Src kinase 
activity. Furthermore, significant increase in the c-Src level has also been detected in the 
testis after cadmium exposure in rodents, indicating that c-Src is activated in response to 
multiple environmental toxicants (Wong et al., 2004; Wong & Cheng, 2011) (Figure 6).  
The MAPK pathways have emerged as a common signaling platform for multiple 
environmental toxicants (Figure 6). Three MAPKs (extracellular-signal-regulated kinase 
(ERK), c-Jun N-terminal kinase (JNK) and p38) have been shown to be activated in the testis 
after exposure to environmental toxicants. MAPKs are involved in regulating normal 
reproductive functions in the testis, which include spermatogenesis (e.g. cell-cycle 
progression, meiosis, BTB dynamics, cell adhesion dynamics and spermiogenesis), 
steroidogenesis, sperm hyperactivation and acrosome reaction (Almog & Naor 2010). As a 
result, unregulated activation of MAPKs by environmental toxicants imposes an array of 
pathophysiological effects on Sertoli cells, germ cells and Leydig cells in the testis. These 
include an increase in DNA damage and apoptosis, disruption of cell junctions and 
steroidogenesis (Li et al., 2009; Wong & Cheng, 2011). MAPKs are activated by oxidative 
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stress induced by environmental toxicants in cells and tissues. For example, blocking 
oxidative stress by free-radical scavengers (e.g. N-acetyl cysteine), reverses cadmium-
induced MAPK activation (Chen, et al., 2008). This phenomenon is partly regulated by the 
inhibition of Ser/Thr protein phosphatases 2A (PP2A) and 5 (PP5) by oxidative stress, 
which results in an increase in phosphorylation of MAPK (Chen, et al., 2008). In addition, 
activation of ERK can lead to phosphorylation of c-Src, FAK and paxillin under oxidative 
stress, implying that MAPKs might be one of the upstream targets to activate these non-
receptor tyrosine kinases (Li et al., 2009) (Figure 6). Activation of MAPKs by environmental 
toxicants also upregulates the expression of proinflammatory cytokines such as nuclear 
factor kB (NFkB), and tumor necrosis factor-ǂ (TNFǂ) in macrophages and monocytes 
(Lecureur et al., 2005), which can diffuse from microvessels in the interstitial space and 
disrupt the BTB because they are known to perturb the Sertoli cell TJ-permeability barrier 
(Li et al., 2009). Similarly, cadmium and pollutants from motorcycle exhausts (e.g. polycyclic 
aromatic hydrocarbons) increase the expression of transforming growth factor-ǃ (TGF-ǃ) 
and interleukin-6 (IL-6) in the testis, respectively (Lui et al., 2009). TNFǂ, TGF-ǃ and IL-1ǂ 
are known to disrupt Sertoli–Sertoli and Sertoli–germ cell junctions via downregulation (Li 
et al., 2006) and/or redistribution of junctional proteins (Wong & Cheng, 2005) such as 
occludin, ZO-1 and N-cadherin in the seminiferous epithelium. Consequently, the loss of 
integral membrane proteins at the cell–cell interface causes disruption of the BTB and 
adhesion of germ cells in the seminiferous epithelium, which lead to the premature release 
of germ cells from the epithelium and hence infertility (Li et al., 2006; Li et al., 2009; Wong & 
Cheng, 2011). Furthermore, proinflammatory cytokines (e.g. IL-6 and TNFǂ) activate 
leukocytes to produce ROS, which amplifies the deleterious effects of environmental 
toxicant-induced oxidative stress (Tremellen, 2008). The male reproductive system has 
emerged as one of the major targets of environmental toxicants. Although acute exposure to 
toxicants contributes to apoptosis and the necrosis of testicular cells, chronic and sub-lethal 
exposure is prevailing in the general public (Hauser & Sokol 2008). Due to the unusually 
long half-lives of some of these toxicants in the mammalian body (e.g. cadmium has a mean 
half-life of >15 years), chronic and low-level exposure to humans could cause long-term 
unwanted health effects. The disruptive effects of environmental toxicants on cell junctions 
mediated by non-receptor tyrosine kinases (e.g. c-Src and FAK) and cytokines through 
oxidative stress because such damage is often observed in low-level exposure before 
apoptosis occurs (Li et al., 2006; Li et al., 2009). Significantly, these signalling pathways 
converge to utilize polarity proteins to regulate intercellular junctions. Polarity proteins 
(which are known to control cell adhesion in the testis) thus emerge as novel targets for 
therapeutic intervention to limit environmental toxicant-induced infertility. Although it is 
equally important to study the epigenetic (e.g. vinclozolin) and endocrine-disruptive (e.g. 
BPA, dioxin, cadmium) effects of environmental toxicants, it is increasingly clear that these 
toxicants are imposing an immediate deleterious effect in the testis via disruption of cell 
junctions between testicular cells due to increase in oxidative stress. In addition, endocrine-
disrupting toxicants that affect estrogen levels might cause a disturbed balance of ROS and 
oxidative stress because estrogen is an important free-radical scavenger in humans, besides 
being essential for spermatogenesis (Carreau  and Hess, 2010). 
Recent studies have emphasized the importance of assessing the effects of a mixture of 
environmental toxicants on male reproductive function because humans are exposed to an 
array of chemicals that might antagonize or agonize each other (Hauser & Sokol 2008). 
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Although this type of study is inherently difficult to undertake, it is crucial for a full 
understanding of the impact of environmental toxicants on the reproductive system. 
However, much work is needed to understand the precise molecular events and 
mechanism(s) regulated by environmental toxicants to target c-Src, FAK, MAPK and 
polarity proteins in the testis. Only then can we identify specific phosphorylation targets or 
isoforms so that small-molecule agonists and/or antagonists can be designed to limit 
systemic toxicity in vivo. 
 
 
 
Fig. 5. Primary pathologies of male reproductive system in connection with environmental 
toxins, oxidative stress and infertility.  
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Fig. 6. Molecular signalling pathways of testicular toxicity by environmental toxicants 
through the induction of oxidative stress. Oxidative stress induced by environmental 
toxicants activates the PI3K/ C-src/FAK pathway, which subsequently controls the 
phosphorylation of TJ and/or AJ proteins. This leads to the internalization of TJ and AJ 
proteins at the cell–cell interface. In addition, environmental toxicants induce the production 
of cytokines which are also regulated by the activation of MAPK through oxidative stress. 
Cytokines stimulate the production of reactive oxygen species (ROS) from leukocytes to 
further increase oxidative stress. Cytokines and the activation of MAPK together result in 
endocytic vesicle- mediated internalization of TJ and AJ proteins. Polarity proteins such as 
Par6 are also involved in mediating the action of cytokines to recruit the E3 ubiquitin ligase 
Smurf1 for the poly ubiquitination and degradation of RhoA, which is important for the 
disruption of cell junctions. This illustrates that crosstalk exists between the PI3K/C-
Src/FAK and cytokines/ MAPK pathways via polarity proteins as their common 
downstream signalling mediators. The disruption of cell junctions ultimately leads to the 
germ cell apoptosis and necrosis and as a result sperm count and quality of semen are 
reduced. (Modified from Wong & Cheng, Trends in Pharmacological Sciences, 2011). 
5. Conclusions 
In view of the fact that the preliminary concerns arose about environmental chemicals or 
toxins and declining sperm counts, there has been an explosion of research in this area. The 
initial ‘environmental oestrogen’ hypothesis has been superseded by a more refined 
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definition of EDCs. It is now accepted that there are a plethora of ways in which the 
environmental chemicals can potentially act on the endocrine as well as male reproductive 
systems. Though supportive data must need to determine whether human male 
reproductive health is declining  or not. However; the hypothesis of a ‘testicular dysgenesis 
syndrome’ is an important advancement and may aid our understanding of the underlying 
aetiology of these disorders. Within the reproductive tract, the male is exquisitely vulnerable 
to the effects of anti-androgens during development due the dependence on the synthesis 
and action of androgens for the masculinization of the male reproductive tract. The ability of 
phthalates to suppress androgen synthesis during development and to induce testicular 
dysgenesis together with cryptorchidism and hypospadias has close parallels with human 
TDS. However, the crucial question regarding whether the level of environmental chemicals 
is sufficient to impact on human male reproductive health remains unanswered, although 
advances will be made from studying the effects of multi-component EDC mixtures in both 
in vitro and in vivo test systems. Moreover, it has been observed that in wildlife, there is a 
increasing rates of testicular cancer, to the debate regarding trends in sperm counts, there 
has been increasing concern that hazardous substances in the environment adversely affect 
male reproductive health. The ultimate benefits of this chapter that should serve as a 
framework for future studies to improve our knowledge in this area. By better defining the 
problems, learning about the mechanisms responsible for adverse effects, and developing 
panels of relevant biomarkers, we will make progress toward preventing future adverse 
effects on male reproductive health. 
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